<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotic treatment for newborns with congenital syphilis - Walker, GJA - 2019 | Cochrane Library</title> <meta content="Antibiotic treatment for newborns with congenital syphilis - Walker, GJA - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012071.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotic treatment for newborns with congenital syphilis - Walker, GJA - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012071.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012071.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotic treatment for newborns with congenital syphilis" name="citation_title"/> <meta content="Godfrey JA Walker" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="godfrey.walker64@alumni.ic.ac.uk" name="citation_author_email"/> <meta content="Damian Walker" name="citation_author"/> <meta content="Bill &amp; Melinda Gates Foundation" name="citation_author_institution"/> <meta content="Daniel Molano Franco" name="citation_author"/> <meta content="Fundacion Universitaria de Ciencias de la Salud, Hospital de San José" name="citation_author_institution"/> <meta content="Carlos F Grillo‐Ardila" name="citation_author"/> <meta content="Faculty of Medicine, Universidad Nacional de Colombia" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD012071.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/02/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012071.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012071.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012071.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Bacterial Agents [*therapeutic use]; Infant Mortality; Penicillin G Benzathine [*therapeutic use]; Penicillin G Procaine [*therapeutic use]; Randomized Controlled Trials as Topic; Syphilis, Congenital [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012071.pub2&amp;doi=10.1002/14651858.CD012071.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012071\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012071\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","pl","fr","zh_HANS","fa","hu"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012071.pub2",title:"Antibiotic treatment for newborns with congenital syphilis",firstPublishedDate:"Feb 15, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane STI Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012071.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012071.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012071.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012071.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012071.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012071.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012071.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012071.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012071.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012071.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12022 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012071.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-sec-0112"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-sec-0047"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-sec-0048"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-sec-0073"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-sec-0106"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/appendices#CD012071-sec-0117"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/table_n/CD012071StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/table_n/CD012071StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotic treatment for newborns with congenital syphilis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information#CD012071-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Godfrey JA Walker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information#CD012071-cr-0003">Damian Walker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information#CD012071-cr-0004">Daniel Molano Franco</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information#CD012071-cr-0005">Carlos F Grillo‐Ardila</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information/en#CD012071-sec-0121">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 February 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012071.pub2">https://doi.org/10.1002/14651858.CD012071.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012071-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012071-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012071-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012071-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012071-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012071-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012071-abs-0001" lang="en"> <section id="CD012071-sec-0001"> <h3 class="title" id="CD012071-sec-0001">Background</h3> <p>Congenital syphilis continues to be a substantial public health problem in many parts of the world. Since the first use of penicillin for the treatment of syphilis in 1943, which was a notable early success, it has remained the preferred and standard treatment including for congenital syphilis. However, the treatment of congenital syphilis is largely based on clinical experience and there is extremely limited evidence on the optimal dose or duration of administration of penicillin or the use of other antibiotics. </p> </section> <section id="CD012071-sec-0002"> <h3 class="title" id="CD012071-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of antibiotic treatment for newborns with confirmed, highly probable and possible congenital syphilis. </p> </section> <section id="CD012071-sec-0003"> <h3 class="title" id="CD012071-sec-0003">Search methods</h3> <p>We searched the Cochrane STI Group Specialized Register, CENTRAL, MEDLINE, Embase, LILACS, WHO ICTRP, ClinicalTrials.gov and Web of Science to 23 May 2018. We also handsearched conference proceedings, contacted trial authors and reviewed the reference lists of retrieved studies. </p> </section> <section id="CD012071-sec-0004"> <h3 class="title" id="CD012071-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing antibiotic treatment (any concentration, frequency, duration and route) with no intervention or any other antibiotic treatment for neonates with confirmed, highly probable or possible congenital syphilis. </p> </section> <section id="CD012071-sec-0005"> <h3 class="title" id="CD012071-sec-0005">Data collection and analysis</h3> <p>All review authors independently assessed trials for inclusion, extracted data and assessed the risk of bias in the included studies. We resolved any disagreements through consensus. We assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD012071-sec-0006"> <h3 class="title" id="CD012071-sec-0006">Main results</h3> <p>Two RCTs (191 participants) met our inclusion criteria and none of these trials was funded by the industry. One trial (22 participants) compared benzathine penicillin with no intervention for infants with possible congenital syphilis. Low‐quality evidence suggested that benzathine penicillin administration may not have decreased the rate of neonatal death due to any cause (risk ratio (RR) 0.83, 95% confidence interval (CI) 0.06 to 11.70), and showed a possible reduction into the proportion of neonates with clinical manifestations of congenital syphilis (RR 0.12, 95% CI 0.01 to 2.09). Penicillin administration increased the serological cure at the third month (RR 2.13, 95% CI 1.06 to 4.27). These results should be taken with caution, because the trial was stopped early because there were four cases with clinical congenital syphilis in the no treatment group and none in the treatment group. Interim analysis suggested this difference was significant. This study did not report neonatal death due to congenital syphilis or the frequency of serious or minor adverse events after therapy. We downgraded the quality of evidence because of imprecision and risk of bias. </p> <p>One trial (169 participants) compared benzathine penicillin versus procaine benzylpenicillin. High‐ and moderate‐quality evidence suggested that there were probably no differences between benzathine penicillin and procaine benzylpenicillin for the outcomes: absence of clinical manifestations of congenital syphilis (RR 1.00, 95% CI 0.97 to 1.03) and serological cure (RR 1.00, 95% CI 0.97 to 1.03). There were no cases of neonatal death due congenital syphilis; all 152 babies who followed up survived. This study did not report on the frequency of serious or minor adverse events after therapy. We downgraded the quality of evidence because of serious risk of bias. </p> </section> <section id="CD012071-sec-0007"> <h3 class="title" id="CD012071-sec-0007">Authors' conclusions</h3> <p>At present, the evidence on the effectiveness and safety of antibiotic treatment for newborns with confirmed, highly probable or possible congenital syphilis is sparse, implying that we are uncertain about the estimated effect. One trial compared benzathine penicillin with no intervention for infants with possible congenital syphilis. Low‐quality evidence suggested penicillin administration possibly reduce the proportion of neonates with clinical manifestations of congenital syphilis, penicillin administration increased the serological cure at the third month. These findings support the clinical use of penicillin in neonates with confirmed, highly probable or possible congenital syphilis. High‐ and moderate‐quality evidence suggests that there are probably no differences between benzathine penicillin and procaine benzylpenicillin administration for the outcomes of absence of clinical manifestations of syphilis or serological cure. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012071-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012071-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012071-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012071-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012071-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hu#CD012071-abs-0014">Magyar</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012071-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012071-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012071-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012071-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012071-abs-0004" lang="en"> <h3>Which antibiotic are useful to treat newborns with congenital syphilis?</h3> <p><b>Review question</b> </p> <p>To assess the effectiveness and safety of antibiotic treatment for newborns with congenital syphilis. </p> <p><b>Background</b> </p> <p>Pregnant women with syphilis can transmit it through the placenta to the fetus or at birth to the neonate; in such cases the baby is said to have congenital syphilis. This continues to be a substantial public health problem in many countries. In 2007, the World Health Organization launched a global initiative for the elimination of mother‐to‐child transmission of syphilis. </p> <p><b>Trial characteristics</b> </p> <p>We identified only two clinical trials following extensive searches of medical databases carried out up to 23 May 2018 and involved two main formulations of penicillin, long‐acting benzathine penicillin and procaine benzylpenicillin. Both trials recruited infants with asymptomatic (no symptoms) congenital syphilis. The first with 22 newborns was undertaken in South Africa and compared benzathine penicillin with no treatment. The second trial was carried out in USA and recruited 169 infants and compared the effectiveness of benzathine penicillin and procaine benzylpenicillin. </p> <p><b>Key results</b> </p> <p>The first study showed there was not difference in the rate of neonatal death due to any cause, moreover results suggested a possible reduction into the proportion of neonates with clinical manifestations of congenital syphilis. Also penicillin administration increase the number of patients who experience a favourable response in terms of the test used to monitor disease activity (serological cure). This trial was stopped early after there were four cases of congenital syphilis found in the no‐treatment group and none in the penicillin group. </p> <p>The second trial showed that both benzathine penicillin and procaine benzylpenicillin were probably equally effective in treating congenital syphilis for the outcomes absence of clinical manifestations of congenital syphilis and serological cure. None of the studies assessed the side effects of treatment. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence for the first trial was low due to poor reporting of study methods. For the second trial, there was high‐quality evidence for the absence of clinical manifestations of congenital syphilis on neonates, but moderate‐quality evidence for serological cure due to few data. </p> <p><b>Conclusions</b> </p> <p>Compared with no intervention, treatment with benzathine penicillin may increase rates of serological cure by the age of three months and possibly reduce the the clinical manifestation of congenital syphilis. There is probably no difference between long‐acting benzathine penicillin and procaine benzylpenicillin for treating newborns with congenital syphilis. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012071-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012071-sec-0112"></div> <h3 class="title" id="CD012071-sec-0113">Implications for practice</h3> <section id="CD012071-sec-0113"> <p>At present, althougth the evidence from randomised controlled trials (RCTs) on the effectiveness and safety of antibiotic treatment for newborns with confirmed, highly probable or possible congenital syphilis is sparse, and was qualified as low‐quality evidence. Pencillin administration suggests there is possibly effect into reduction of the proportion of neonates with clinical manifestations of congenital syphilis and increasing the serological cure at the third month. These results support the current clinical practice of treating with penicillin those newborns diagnosed with confirmed, highly probable or possible congenital syphilis. High‐ and moderate‐quality evidence, suggests that there are probably no differences between benzathine penicillin and procaine benzylpenicillin treatment for the outcomes of absence of clinical manifestations of congenital syphilis or serological cure. The findings of this review support the recommendations from guideline development groups, which propose these therapeutic alternatives for the treatment of babies born with confirmed, highly probable or possible congenital syphilis (<a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>; <a href="./references#CD012071-bbs2-0092" title="World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis). Geneva: WHO, 2016. ">WHO 2016</a>). </p> </section> <h3 class="title" id="CD012071-sec-0114">Implications for research</h3> <section id="CD012071-sec-0114"> <p>Althougth evidence about the effectivennes of penicillin against no treatment because were mainly driven by one trial, it would be very difficult to make another clinical tral comaring those alternatives because ethical concerns. Studies are needed to evaluate treatment failure cases with currently recommended regimens and this should include an assessment of the role of HIV infection in cases of congenital syphilis treatment failure. Uncertainty remains regarding serious adverse effects of treatment and these should be documented in future studies. There are few data on the use of antibiotics other than penicillin such as ceftriaxone for treatment of infants with confirmed or highly probable congenital syphilis and research is needed in comparing other antibiotics to procaine benzylpenicillin and benzathine penicillin. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012071-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012071-sec-0036"></div> <div class="table" id="CD012071-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic treatment compared to no intervention for newborns with congenital syphilis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Antibiotic treatment compared to no intervention for newborns with congenital syphilis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> newborns with congenital syphilis<br/> <b>Setting:</b> inpatient clinic<br/> <b>Intervention:</b> antibiotic treatment<br/> <b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal death rate due congenital syphilis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neonatal death rate due any cause</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000<br/> (6 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b><br/> (0.06 to 11.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Absence of clinical manifestations of congenital syphilis during follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>36 per 1000<br/> (3 to 627) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.12</b><br/> (0.01 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serological cure (≥ 4‐fold decrease in non‐treponemal tests titre)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>947 per 1000<br/> (471 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.13</b><br/> (1.06 to 4.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor adverse events of therapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations on other bias domain (stopped early rule due to apparent benefit). </p> <p><sup>b</sup>Downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012071-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for newborns with congenital syphilis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for newborns with congenital syphilis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> newborns with congenital syphilis<br/> <b>Setting:</b> inpatient clinic<br/> <b>Intervention:</b> antibiotic treatment (benzathine penicillin)<br/> <b>Comparison:</b> any other antibiotic (procaine benzylpenicillin) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any other antibiotic (procaine benzylpenicillin)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic treatment (benzathine penicillin)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal death rate due congenital syphilis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>There were 0 cases of neonatal death due congenital syphilis.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal death rate due to any cause</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Absence of clinical manifestations of congenital syphilis during follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (970 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b><br/> (0.97 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serological cure (4‐fold decrease or greater in non‐treponemal tests titre)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (970 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b><br/> (0.97 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor adverse events of therapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations on incomplete outcome data domain. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012071-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012071-sec-0037"></div> <section id="CD012071-sec-0038"> <h3 class="title" id="CD012071-sec-0038">Description of the condition</h3> <p>Congenital syphilis continues to be a substantial public health problem in many parts of the world (<a href="./references#CD012071-bbs2-0087" title="WalkerDG , WalkerGJA . Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infectious Diseases2002;2:432‐6. ">Walker 2002</a>; <a href="./references#CD012071-bbs2-0016" title="ConwayJH . Recognizing and reducing the global burden of congenital syphilis: the time is now. Sexually Transmitted Diseases2007;34(7 Suppl):S2‐4. ">Conway 2007</a>; <a href="./references#CD012071-bbs2-0045" title="MabeyD , PeelingRW . Syphilis, still a major cause of infant mortality. Lancet Infectious Diseases2011;11(9):684‐91. ">Mabey 2011</a>; <a href="./references#CD012071-bbs2-0053" title="NewmanL , KambM , HawkesS , GomezG , SayL , SeucA . Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Medicine2013;10(2):1‐9. ">Newman 2013</a>). Subsequent perinatal mortality and morbidity associated with maternal infection with syphilis exceeds that from other infections (<a href="./references#CD012071-bbs2-0022" title="FollettT , ClarkeDF . Resurgence of congenital syphilis: diagnosis and treatment. Neonatal Network2011;30(5):320‐8. ">Follett 2011</a>). It has received less attention than mother‐to‐child transmission of HIV, and the prospect of avoiding infection with HIV and dying from syphilis has been raised as a disastrous possibility (<a href="./references#CD012071-bbs2-0055" title="PeelingRW , MabeyD , FitzgeraldDW , Watson‐JonesD . Avoiding HIV and dying of syphilis. Lancet2004;364:1561‐3. ">Peeling 2004</a>; <a href="./references#CD012071-bbs2-0080" title="TaylorM , Alonso‐González , M , GomezB , KorenrompE , BroutetN . World Health Organization global health sector strategy on sexually transmitted infections: an evidence‐to‐action summary for Colombia [Estrategia global de la Organización Mundial de la Salud contra infecciones de transmisión sexual: de la evidencia a la acción]. Revista Colombiana de Obstetricia y Ginecologia2017;68(3):193‐201. ">Taylor 2017a</a>). In 2012, the World Health Organization (WHO) estimated that 930,000 pregnant women experience 350,000 adverse pregnancy outcomes annually due to syphilis. However, while countries frequently have well‐resourced programmes for HIV prevention and care, syphilis control is seldom centralised and often falls within the responsibilities, but outside the priorities, of HIV programmes or antenatal care (<a href="./references#CD012071-bbs2-0081" title="TaylorMM , KamM , WuD , HawkesS . Syphilis screening and treatment: integration with HIV services. Bulletin of the World Health Organization2017;95:610‐610A. ">Taylor 2017b</a>). Not only is the disease burden from congenital syphilis substantial on individuals and families, but also the management of the sequelae of the infection can place appreciable costs on health services (<a href="./references#CD012071-bbs2-0008" title="BatemanDA , PhibbsCS , JoyceT , HeagartyMC . The hospital cost of congenital syphilis. Journal of Pediatrics1997;130(5):752‐8. ">Bateman 1997</a>; <a href="./references#CD012071-bbs2-0054" title="Owusu‐EduseiKJ , IntrocasoCE , ChessonHW . Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States. Sexually Transmitted Diseases2013;40(3):226‐9. ">Owusu‐Edusei 2013</a>). </p> <p>Congenital syphilis is a systemic infection in which a baby might have been delivered prematurely. The classic description of the congenital syphilitic baby is a severely infected premature infant with marasmus, a pot belly, an 'old man face' and withered skin. Congenital syphilis is a serious condition which, if not fatal at a young age, can cause permanent impairment, debilitation and disfigurement from the stigmata associated with this condition (<a href="./references#CD012071-bbs2-0013" title="ChakrabortyR , LuckS . Syphilis is on the increase: the implications for child health. Archives of Disease in Childhood2008;93(2):105‐9. ">Chakraborty 2008</a>; <a href="./references#CD012071-bbs2-0065" title="RichensJ , MabeyCW . Sexually transmitted infections (excluding HIV). In: CookG , ZumlaA editor(s). Manson's Tropical Diseases. 22nd Edition. London: Saunders Elsevier, 2008. ">Richens 2008</a>; <a href="./references#CD012071-bbs2-0075" title="SparlingPF , SwartzMN , MusherDM , HealyBP . Clinical manifestations of syphilis. In: HolmesKK , SparlingPF , StammWE , PiotP , WasserheitJN , CoreyL , et al. editor(s). Sexually Transmitted Diseases. 4th Edition. New York (NY): McGraw Hill Medical, 2008. ">Sparling 2008</a>). A wide spectrum of severity exists, from inapparent infection to severe cases that are clinically present at birth. An infant or child (aged less than two years) may have signs such as hepatosplenomegaly, rash, condyloma lata, snuffles, jaundice (non‐viral hepatitis), pseudoparalysis, anaemia or oedema (nephrotic syndrome or malnutrition, or both). An older child may have stigmata (e.g. interstitial keratitis, nerve deafness, anterior bowing of shins, frontal bossing, mulberry molars, Hutchinson teeth, saddle nose, rhagades or Clutton joints) (see Centers for Disease Control (CDC) Congenital Syphilis Definitions ‐ Revised January 2015 <a href="http://www.cdc.gov/std/stats/congenitalsyphilisdef-rev-jan-2015.pdf" target="_blank">www.cdc.gov/std/stats/congenitalsyphilisdef‐rev‐jan‐2015.pdf</a>). </p> <p>Syphilis is caused by the spirochete, <i>Treponema pallidum</i> (<i>T pallidum</i>). Most cases of congenital syphilis arise from in utero infection, although a mother can rarely transmit syphilis to her baby at the time of delivery (<a href="./references#CD012071-bbs2-0073" title="ShafiiT , RadolfJD , SanchezPJ , SchulzKF , MurphyFK . Congenital syphilis. In: HolmesKK , SparlingPF , StammWE , PiotP , WasserheitJN , CoreyL , et al. editor(s). Sexually Transmitted Diseases. 4th Edition. New York (NY): McGraw Hill Medical, 2008. ">Shafii 2008</a>). Syphilis can be transmitted transplacentally at all stages during the course of untreated maternal disease, from incubation, through primary, secondary, latent and tertiary syphilis (<a href="./references#CD012071-bbs2-0019" title="DoroshenkoA , SherrardJ , PollardAJ . Syphilis in pregnancy and the neonatal period. International Journal of STD &amp; AIDS2006;17(4):221‐7. ">Doroshenko 2006</a>). The risk to the foetus or baby varies considerably according to the stage of untreated syphilis of the mother, and decreases as maternal disease progresses (<a href="./references#CD012071-bbs2-0013" title="ChakrabortyR , LuckS . Syphilis is on the increase: the implications for child health. Archives of Disease in Childhood2008;93(2):105‐9. ">Chakraborty 2008</a>). Infectivity and severity of untreated syphilis in pregnant women becomes less with each successive pregnancy (<a href="./references#CD012071-bbs2-0013" title="ChakrabortyR , LuckS . Syphilis is on the increase: the implications for child health. Archives of Disease in Childhood2008;93(2):105‐9. ">Chakraborty 2008</a>; <a href="./references#CD012071-bbs2-0026" title="GomezGB , KambML , NewmanLM , MarkJ , BroutetN , HawkesSJ . Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta‐analysis. Bulletin of the World Health Organization2013;91:217‐26. ">Gomez 2013</a>). </p> <p>In most middle‐ and low‐income countries syphilis is endemic and congenital syphilis continues to be a serious public health problem (<a href="./references#CD012071-bbs2-0024" title="GichangiP , RenterghemLV , KaranjaJ , BwayoJ , KiraguD , TemmermanM . Congenital syphilis in a Nairobi hospital. East African Medical Journal2004;81(11):589‐93. ">Gichangi 2004</a>; <a href="./references#CD012071-bbs2-0010" title="BeltramiJ , BermanS . Congenital syphilis: a persisting sentinel public health event. Sexually Transmitted Diseases2006;33(11):675‐6. ">Beltrami 2006</a>; <a href="./references#CD012071-bbs2-0088" title="WalkerGJ , WalkerDG . Congenital syphilis: a continuing but neglected problem. Seminars in Fetal &amp; Neonatal Medicine2007;12(3):198‐206. ">Walker 2007</a>; <a href="./references#CD012071-bbs2-0026" title="GomezGB , KambML , NewmanLM , MarkJ , BroutetN , HawkesSJ . Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta‐analysis. Bulletin of the World Health Organization2013;91:217‐26. ">Gomez 2013</a>; <a href="./references#CD012071-bbs2-0053" title="NewmanL , KambM , HawkesS , GomezG , SayL , SeucA . Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Medicine2013;10(2):1‐9. ">Newman 2013</a>). It is a major cause of perinatal mortality and morbidity, particularly in sub‐Saharan Africa, and remains the leading cause of perinatal mortality, resulting in an estimated 21% of all perinatal deaths and about a third of stillbirths (<a href="./references#CD012071-bbs2-0073" title="ShafiiT , RadolfJD , SanchezPJ , SchulzKF , MurphyFK . Congenital syphilis. In: HolmesKK , SparlingPF , StammWE , PiotP , WasserheitJN , CoreyL , et al. editor(s). Sexually Transmitted Diseases. 4th Edition. New York (NY): McGraw Hill Medical, 2008. ">Shafii 2008</a>). The WHO estimated in 2006 that the global annual incidence of congenital syphilis (including miscarriages, perinatal deaths, premature births/low birthweight babies and neonatal infections) was between 713,600 and 1,575,000 (<a href="./references#CD012071-bbs2-0090" title="World Health Organization. The Global Elimination of Congenital Syphilis: Rationale and Strategy for Action. Geneva: WHO, 2007. ">WHO 2007</a>). Estimates for 2008 based on modelling have produced lower figures, with a mid‐case scenario of 520,000 perinatal adverse outcomes due to maternal syphilis infection (215,000 stillbirths, 90,000 neonatal deaths, 65,000 preterm or low birthweight infants and 150,000 newborns infected with congenital syphilis) (<a href="./references#CD012071-bbs2-0053" title="NewmanL , KambM , HawkesS , GomezG , SayL , SeucA . Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Medicine2013;10(2):1‐9. ">Newman 2013</a>). Whatever the correct figures, there is no doubt that syphilis adversely affects more perinates than any other major neonatal infection including HIV infection and tetanus (<a href="./references#CD012071-bbs2-0022" title="FollettT , ClarkeDF . Resurgence of congenital syphilis: diagnosis and treatment. Neonatal Network2011;30(5):320‐8. ">Follett 2011</a>). </p> <p>In many 'affluent' countries since the late 1990s, there have been, from very low levels, increases in the numbers of congenital syphilis cases. This has been associated with the near epidemic increase during the late 20th and early 21st centuries in the incidence of primary and secondary syphilis among young females, particularly among inner‐city minorities, and often associated with the use of crack cocaine and the exchange of illegal drugs for sex among multiple sex partners and men who have sex with men, as an infectious focus for women (<a href="./references#CD012071-bbs2-0048" title="McFarlinBL , BottomsSF , DockBS , IsadaNB . Epidemic syphilis: maternal factors associated with congenital infection. American Journal of Obstetrics and Gynecology1994;150(2):535‐40. ">McFarlin 1994</a>; <a href="./references#CD012071-bbs2-0073" title="ShafiiT , RadolfJD , SanchezPJ , SchulzKF , MurphyFK . Congenital syphilis. In: HolmesKK , SparlingPF , StammWE , PiotP , WasserheitJN , CoreyL , et al. editor(s). Sexually Transmitted Diseases. 4th Edition. New York (NY): McGraw Hill Medical, 2008. ">Shafii 2008</a>). In middle‐ and low‐income countries, lack and poor quality of antenatal care appear to be the most important risk factors for increasing numbers of mothers giving birth to babies with congenital syphilis (<a href="./references#CD012071-bbs2-0025" title="GloydS , ChaiS , MercerMA . Antenatal syphilis in sub‐Saharan Africa: missed opportunities for mortality reduction. Health Policy and Planning2001;16(1):29‐34. ">Gloyd 2001</a>; <a href="./references#CD012071-bbs2-0087" title="WalkerDG , WalkerGJA . Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infectious Diseases2002;2:432‐6. ">Walker 2002</a>; <a href="./references#CD012071-bbs2-0018" title="DesperthesBD , MeheusA , O'ReillyK , BroutetN . Maternal and congenital syphilis programmes: case studies in Bolivia, Kenya and South Africa. Bulletin of the World Health Organization2004;82(6):410‐6. ">Desperthes 2004</a>; <a href="./references#CD012071-bbs2-0066" title="RodriguesCS , GuimarãesMD , CésarCC . Missed opportunities for congenital syphilis and HIV perinatal transmission prevention. Revista de Saude Publica2008;42(6):851‐8. ">Rodrigues 2008</a>; <a href="./references#CD012071-bbs2-0094" title="World Health Organization, United Nations Programme on HIV/AIDS, UNICEF . Global HIV/AIDS Response – Epidemic Update and Health Sector Progress towards Universal Access – Progress Report 2011. Geneva: WHO, 2012. ">WHO, UNAIDS, UNICEF 2012</a>; <a href="./references#CD012071-bbs2-0014" title="Cifuentes‐CifuentesMY , Ojeda‐EnríquezCV . The congenital syphilis protocol used at the Instituto Materno Infantil‐Hospital la Victoria, Bogotá [Sífilis congénita en el Instituto Materno Infantil‐Hospital la Victoria, Bogotá]. Revista de Saude Publica2013;15(3):434‐45. ">Cifuentes‐Cifuentes 2013</a>; <a href="./references#CD012071-bbs2-0017" title="CruzAR , CastrillonMA , MinottaAY , RubianoLC , CastanoMC , SalazarJC . Gestational and congenital syphilis epidemic in the Colombian Pacific Coast. Sexually Transmitted Diseases2013;40(10):813‐9. ">Cruz 2013</a>). </p> <p>A mainstay of the prevention of congenital syphilis has been, and continues to be, screening of pregnant women to identify those who have syphilis, followed by treatment (<a href="./references#CD012071-bbs2-0087" title="WalkerDG , WalkerGJA . Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infectious Diseases2002;2:432‐6. ">Walker 2002</a>; <a href="./references#CD012071-bbs2-0031" title="HawkesS . Eliminating congenital syphilis – if not now then when?. Sexually Transmitted Diseases2009;36(11):721‐3. ">Hawkes 2009</a>; <a href="./references#CD012071-bbs2-0050" title="MunkhuuB , LiabsuetrakulT , ChongsuvivatwongV , McNeilE , JanchivR . One‐stop service for antenatal syphilis screening and prevention of congenital syphilis in Ulaanbaatar, Mongolia: a cluster randomized trial. Sexually Transmitted Diseases2009;36(11):714‐20. ">Munkhuu 2009</a>; <a href="./references#CD012071-bbs2-0056" title="PeelingR , MabeyD , BallardRC . Introducing new diagnostics into STI control programmes: the importance of programme science. Sexually Transmitted Infections2012;89(2):115‐9. [DOI: 10.1136/sextrans‐2012‐050617] ">Peeling 2012</a>; <a href="./references#CD012071-bbs2-0057" title="PeelingR . Breaking the silence on syphilis, 2013. www.trust.org/item/20130228145900‐1dik0/?source=search (accessed prior to 19 November 2018). ">Peeling 2013</a>). Although there have been concerns about its cost‐effectiveness (<a href="./references#CD012071-bbs2-0082" title="Terris‐PrestholtF , Watson‐JonesD , MugeyeK , KumaranayakeL , NdekiL , WeissH , et al. Is antenatal syphilis screening still cost effective in sub‐Saharan Africa?. Sexually Transmitted Infections2003;79(5):375‐8. ">Terris‐Prestholt 2003</a>), this approach has been shown to be generally cost‐effective (<a href="./references#CD012071-bbs2-0087" title="WalkerDG , WalkerGJA . Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infectious Diseases2002;2:432‐6. ">Walker 2002</a>; <a href="./references#CD012071-bbs2-0070" title="RydzakCE , GoldieSJ . Cost‐effectiveness of rapid point‐of‐care prenatal syphilis screening in sub‐Saharan Africa. Sexually Transmitted Diseases2008;35(9):775‐84. ">Rydzak 2008</a>; <a href="./references#CD012071-bbs2-0034" title="HongFC , LiuJB , FengTJ , LiuXL , PanP , ZhouH , et al. Congenital syphilis: an economic evaluation of a prevention program in China. Sexually Transmitted Diseases2010;37(1):26‐31. ">Hong 2010</a>; <a href="./references#CD012071-bbs2-0011" title="BlencoweH , CousensS , KambM , BermanS , LawnJE . Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health2011;11(Suppl 3):S9. ">Blencowe 2011</a>; <a href="./references#CD012071-bbs2-0091" title="World Health Organization. Investment case for eliminating mother‐to‐child transmission of syphilis: promoting better maternal and child health and stronger health systems. Geneva: Initiative for the Global Elimination of Congenital Syphilis, CDC, WHO and UCL, 2012. ">WHO 2012</a>; <a href="./references#CD012071-bbs2-0041" title="KuznikA , LamordeM , NyabigamboA , ManabeYC . Antenatal syphilis screening using point‐of‐care testing in sub‐Saharan African countries: a cost‐effectiveness analysis. PLoS Medicine2013;10(11):e1001545. [DOI: 10.1371/journal.pmed.1001545] ">Kuznik 2013</a>; <a href="./references#CD012071-bbs2-0079" title="SweeneyS , MoshaJF , Terris‐PrestholtF , SollisKA , KellyH , ChangaluchaJ , PeelingRW . The costs of accessible quality assured syphilis diagnostics: informing quality systems for rapid syphilis tests in a Tanzanian setting. Health Policy and Planning2014;29(5):633‐41. [DOI: 10.1093/heapol/czt049] ">Sweeney 2014</a>). However, antenatal screening and treatment can remain unaffordable in certain low income countrieswhere there are extremely limited resources available for health care (<a href="./references#CD012071-bbs2-0072" title="SchackmanBR , NeukermansCP , FontainSN , NolteC , JosephP , PapeJW , et al. Cost‐effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Medicine2007;4(5):937‐47. ">Schackman 2007</a>; <a href="./references#CD012071-bbs2-0044" title="LomoteyCJ , LewisJ , GebrianB , BourdeauR , DieckhausK , SalazarJC . Maternal and congenital syphilis in rural Haiti. Revista Panamericana de Salud Publica [Pan American Journal of Public Health]2009;26(3):197‐202. ">Lomotey 2009</a>; <a href="./references#CD012071-bbs2-0096" title="WiwanitkitV . Maternal and congenital syphilis in Haiti: a big problem. Revista Panamericana de Salud Publica [Pan American Journal of Public Health]2010;27(6):471. ">Wiwanitkit 2010</a>). A major innovation in the antenatal testing and on‐the‐spot treatment of women found to be infected with syphilis has been the development of point‐of‐care tests (POCTs) (<a href="./references#CD012071-bbs2-0084" title="TuckerJD , BuJ , BrownLB , YinY‐P , ChenX‐S , CohenMS . Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infectious Diseases2010;10:381‐6. ">Tucker 2010a</a>; <a href="./references#CD012071-bbs2-0046" title="MabeyDC , SollisKA , KellyHA , BenzakenAS , BitarakwateE , ChangaluchaJ , et al. Point‐of‐care tests to strengthen health systems and save newborn lives: the case of syphilis. PLoS Medicine2012;9(6):e1001233. [DOI: 10.1371/journal.pmed.1001233] ">Mabey 2012</a>; <a href="./references#CD012071-bbs2-0056" title="PeelingR , MabeyD , BallardRC . Introducing new diagnostics into STI control programmes: the importance of programme science. Sexually Transmitted Infections2012;89(2):115‐9. [DOI: 10.1136/sextrans‐2012‐050617] ">Peeling 2012</a>; <a href="./references#CD012071-bbs2-0086" title="TuckerJD , BienCH , PeelingRW . Point‐of‐care testing for sexually transmitted infections: recent advances and implications for disease control. Current Opinion in Infectious Diseases2013;26(1):73‐9. ">Tucker 2013</a>). For some years, POCTs have been available as an alternative to rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL) testing for syphilis. Unlike RPR, POCTs do not require specialist training or laboratory equipment, and results are available immediately. This allows swift treatment and ends the need for people to return to the clinic to obtain test results (<a href="./references#CD012071-bbs2-0085" title="TuckerJD , ChenXS , PeelingRW . Syphilis and social upheaval in China. New England Journal of Medicine2010;362(18):1658‐61. ">Tucker 2010b</a>; <a href="./references#CD012071-bbs2-0038" title="JafariY , PeelingRW , ShivkumarS , ClaessensC , JosephL , PaiMP . Are Treponema pallidum specific rapid and point‐of‐care tests for syphilis accurate enough for screening in resource limited settings? Evidence from a meta‐analysis. PloS One2013;8(2):e54695. ">Jafari 2013</a>). </p> <section id="CD012071-sec-0039"> <h4 class="title">Diagnosis of congenital syphilis</h4> <p>Diagnosis of congenital syphilis is not straightforward (<a href="./references#CD012071-bbs2-0088" title="WalkerGJ , WalkerDG . Congenital syphilis: a continuing but neglected problem. Seminars in Fetal &amp; Neonatal Medicine2007;12(3):198‐206. ">Walker 2007</a>; <a href="./references#CD012071-bbs2-0073" title="ShafiiT , RadolfJD , SanchezPJ , SchulzKF , MurphyFK . Congenital syphilis. In: HolmesKK , SparlingPF , StammWE , PiotP , WasserheitJN , CoreyL , et al. editor(s). Sexually Transmitted Diseases. 4th Edition. New York (NY): McGraw Hill Medical, 2008. ">Shafii 2008</a>; <a href="./references#CD012071-bbs2-0095" title="WinscottM , TaylorMM , KenneyK . Identifying unreported and undiagnosed cases of congenital syphilis in Arizona. Using live birth and fetal death registries. Sexually Transmitted Diseases2009;37.(4):244‐7. ">Winscott 2009</a>; <a href="./references#CD012071-bbs2-0097" title="WoodsCR . Congenital syphilis? Persisting pestilence. Pediatric Infectious Disease Journal2009;28(6):536‐7. ">Woods 2009</a>; <a href="./references#CD012071-bbs2-0032" title="HerremansT , KortbeekL , NotermansDW . A review of diagnostic tests for congenital syphilis in newborns. European Journal of Clinical Microbiology &amp; Infectious Diseases2010;29:495‐501. ">Herremans 2010</a>; <a href="./references#CD012071-bbs2-0074" title="SinghAE , GuenetteT , GratrixJ , BergmanJ , ParkerP , AndersonB , et al. Seroreversion of treponemal tests in infants meeting Canadian surveillance criteria for confirmed early congenital syphilis. Pediatric Infectious Disease Journal2013;32(3):199‐202. ">Singh 2013</a>; <a href="./references#CD012071-bbs2-0098" title="WrightDJM . Congenital neurosyphilis. Lancet Infectious Diseases2013;13:475. ">Wright 2013</a>), principally because of the transplacental transfer of non‐treponemal/treponemal immunoglobulin (Ig)G antibodies and asymptomatic or non‐specific presentation of congenital syphilis (<a href="./references#CD012071-bbs2-0078" title="StollBJ . Congenital syphilis: evaluation and management of neonates born to mothers with reactive serologic tests for syphilis. Pediatric Infectious Disease Journal1994;13:845‐53. ">Stoll 1994</a>; <a href="./references#CD012071-bbs2-0043" title="LiuJB , HongFC , PanP , ZhouH , YangF , CaiYM , et al. A risk model for congenital syphilis in infants born to mothers with syphilis treated in gestation: a prospective cohort study. Sexually Transmitted Infections2010;86(4):292‐6. ">Liu 2010</a>; <a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>). The diagnosis of congenital syphilis is recognised to be problematic, with more than half of babies asymptomatic at birth and the signs in symptomatic infants often being subtle and non‐specific (<a href="./references#CD012071-bbs2-0005" title="ArnoldSR , Ford‐JonesEL . Congenital syphilis: a guide to diagnosis and management. Paediatrics &amp; Child Health2000;5(8):463‐9. ">Arnold 2000</a>; <a href="./references#CD012071-bbs2-0032" title="HerremansT , KortbeekL , NotermansDW . A review of diagnostic tests for congenital syphilis in newborns. European Journal of Clinical Microbiology &amp; Infectious Diseases2010;29:495‐501. ">Herremans 2010</a>; <a href="./references#CD012071-bbs2-0051" title="MuraliMA , NirmalaC , RaoJV . Symptomatic early congenital syphilis: a common but forgotten disease. Case Reports in Pediatrics2012;2012:934634. ">Murali 2012</a>; <a href="./references#CD012071-bbs2-0007" title="BasuS , KumarA . Case report. varied presentations of early congenital syphilis. Journal of Tropical Pediatrics2013;59(3):246‐9. ">Basu 2013</a>; <a href="./references#CD012071-bbs2-0037" title="IntrocasoCE , BradleyH , GruberD , MarkowitzLE . Missed opportunities for preventing congenital syphilis infection. Sexually Transmitted Diseases2013;40(5):431. ">Introcaso 2013</a>). </p> <p>The most recent CDC Sexually Transmitted Diseases Treatment Guidelines (June 2015) define the following four categories of babies who are more or less likely to have congenital syphilis (<a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>). </p> <section id="CD012071-sec-0040"> <h5 class="title">A. Confirmed or highly probable congenital syphilis</h5> <p>Any neonate with:</p> <p> <ul id="CD012071-list-0001"> <li> <p>an abnormal physical examination that is consistent with congenital syphilis; or</p> </li> <li> <p>a serum quantitative non‐treponemal serologic titre that is four‐fold higher than the mother's titre; or </p> </li> <li> <p>a positive darkfield test or polymerase chain reaction of lesions or body fluid(s).</p> </li> </ul> </p> </section> <section id="CD012071-sec-0041"> <h5 class="title">B. Possible congenital syphilis</h5> <p>Any neonate who has a normal physical examination and a serum quantitative non‐treponemal serological titre of four‐fold or less of the maternal titre, and one of the following: </p> <p> <ul id="CD012071-list-0002"> <li> <p>mother was not treated, inadequately treated or has no documentation of having received treatment; or </p> </li> <li> <p>mother was treated with erythromycin or a regimen other than those recommended (i.e. a non‐penicillin G regimen); or </p> </li> <li> <p>mother received recommended treatment less than four weeks before delivery.</p> </li> </ul> </p> </section> <section id="CD012071-sec-0042"> <h5 class="title">C. Congenital syphilis less likely</h5> <p>Any neonate who has a normal physical examination and a serum quantitative non‐treponemal serological titre of fourfold or less of the maternal titre, and both of the following are true: </p> <p> <ul id="CD012071-list-0003"> <li> <p>mother was treated during pregnancy, treatment was appropriate for the stage of infection and treatment was administered more than four weeks before delivery, and </p> </li> <li> <p>mother had no evidence of reinfection or relapse.</p> </li> </ul> </p> </section> <section id="CD012071-sec-0043"> <h5 class="title">D. Congenital syphilis unlikely</h5> <p>Any neonate who has a normal physical examination and a serum quantitative non‐treponemal serological titre of four‐fold or less of the maternal titre and both of the following are true: </p> <p> <ul id="CD012071-list-0004"> <li> <p>mother’s treatment was adequate before pregnancy and</p> </li> <li> <p>mother’s non‐treponemal serological titre remained low and stable (i.e. serofast) before and during pregnancy and at delivery (VDRL less than 1:2; RPR less than 1:4). </p> </li> </ul> </p> </section> </section> </section> <section id="CD012071-sec-0044"> <h3 class="title" id="CD012071-sec-0044">Description of the intervention</h3> <p>Since the first use of penicillin for the treatment of syphilis by Mahoney in 1943 (<a href="./references#CD012071-bbs2-0083" title="ThomasEW . Rapid treatment of syphilis with penicillin. II Penicillin in prenatal and infantile syphilis. Bulletin of the World Health Organization1949;2:249‐55. ">Thomas 1949</a>; <a href="./references#CD012071-bbs2-0035" title="IdsoeO , GutheT , WillcoxRR . Penicillin in the treatment of syphilis: the experience of three decades. Bulletin of the World Health Organization1972;47(Suppl):S1‐S68. ">Idsoe 1972</a>; <a href="./references#CD012071-bbs2-0047" title="McCrackenGH , KaplanJM . Penicillin treatment for congenital syphilis: a critical appraisal. Journal of the American Medical Association1974;228:855‐8. ">McCracken 1974</a>), its introduction was a notable early success and has remained the preferred treatment of all types of syphilis. This applies to the treatment of congenital syphilis, with penicillin establishing itself as the standard treatment shortly after its discovery. However, the treatment of congenital syphilis is largely based on clinical experience and there is limited evidence on the optimal dose or duration of administration of penicillin (<a href="./references#CD012071-bbs2-0099" title="ZenkerPN , RolfsRT . Treatment of syphilis, 1989. Reviews of Infectious Diseases1990;12 Suppl 6:S590‐609. ">Zenker 1990</a>). </p> <p>Different countries and organisations recommend slightly different regimens of penicillin to treat babies with congenital syphilis (<a href="./references#CD012071-bbs2-0004" title="Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 National Guidelines on the Management of Early Syphilis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD), 2002. ">AGUM and MSSVD 2002</a>; <a href="./references#CD012071-bbs2-0093" title="World Health Organization. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Copenhagen: WHO Euro, 2003. ">WHO Euro 2003</a>; <a href="./references#CD012071-bbs2-0071" title="SaloojeeH , VelaphiS , GogaY , AfadapaN , SteenR , LincettoO . The prevention and management of congenital syphilis: an overview and recommendations. Bulletin of the World Health Organization2004;82(6):424‐30. ">Saloojee 2004</a>; <a href="./references#CD012071-bbs2-0040" title="KingstonM , FrenchP , GohB , GooldP , HigginsS , SukthankarA , et al. Syphilis Guidelines Revision Group 2008, Clinical Effectiveness Group.  UK national guidelines on the management of syphilis 2008. International Journal of STD &amp; AIDS2008;19(11):729‐40. ">Kingston 2008</a>; <a href="./references#CD012071-bbs2-0023" title="FrenchP , GombergM , JanierM , SchmidtB , vanVoorst VaderP , YoungH . IUSTI: 2008 European guidelines on the management of syphilis. International Journal of STD &amp; AIDS2009;20(5):300‐9. ">French 2009</a>; <a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>). Treatment schedules vary between clinicians and different units (<a href="./references#CD012071-bbs2-0021" title="FinelliL , CrayneEM , SpitalnyKC . Treatment of infants with reactive syphilis serology, New Jersey: 1992 to 1996. Pediatrics1998;102(2):e27. ">Finelli 1998</a>), but there are said to be advantages to using standard guidelines for the management of congenital syphilis (<a href="./references#CD012071-bbs2-0042" title="LagoEG , VaccariA , FioriRM . Clinical features and follow‐up of congenital syphilis. Sexually Transmitted Diseases2013;40(2):85‐94. ">Lago 2013</a>). </p> <p>Although well‐documented foetal and infant treatment failures with penicillin are rare (<a href="./references#CD012071-bbs2-0015" title="ConoverCS , RendCA , MillerGBJr , SchmidGP . Congenital syphilis after treatment of maternal syphilis with a penicillin regimen exceeding CDC guidelines. Infectious Diseases in Obstetrics and Gynecology1998;6(3):134‐7. ">Conover 1998</a>), there have been reservations raised about the occasional inadequacy of maternal treatment with penicillin of gestational syphilis in preventing congenital syphilis (<a href="./references#CD012071-bbs2-0062" title="RawstronSA , BrombergK . Failure of recommended maternal therapy to prevent congenital syphilis. Sexually Transmitted Diseases1991;18:102‐6. ">Rawstron 1991</a>; <a href="./references#CD012071-bbs2-0100" title="ZenkerPN , BermanSM . Congenital syphilis: trends and recommendations for evaluation and management. Pediatric Infectious Disease Journal1991;10:516‐22. ">Zenker 1991</a>; <a href="./references#CD012071-bbs2-0049" title="MonifGR . Is current therapy for maternal syphilis inadequate for established fetal infection?. American Journal of Obstetrics and Gynecology1994;170(2):705. ">Monif 1994</a>; <a href="./references#CD012071-bbs2-0078" title="StollBJ . Congenital syphilis: evaluation and management of neonates born to mothers with reactive serologic tests for syphilis. Pediatric Infectious Disease Journal1994;13:845‐53. ">Stoll 1994</a>; <a href="./references#CD012071-bbs2-0064" title="RichardsonMP , PalfreemanA , NielsenPB , FentonKA . Congenital syphilis following negative antenatal screening. Communicable Disease and Public Health / PHLS2002;5:72‐3. ">Richardson 2002</a>; <a href="./references#CD012071-bbs2-0089" title="WendelGDJ , SheffieldJS , HollierLM , HillJB , RamseyPS , SanchezPJ . Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clinical Infectious Diseases2002;35(Suppl 2):S200‐9. ">Wendel 2002</a>; <a href="./references#CD012071-bbs2-0071" title="SaloojeeH , VelaphiS , GogaY , AfadapaN , SteenR , LincettoO . The prevention and management of congenital syphilis: an overview and recommendations. Bulletin of the World Health Organization2004;82(6):424‐30. ">Saloojee 2004</a>) and of treating congenital syphilis (<a href="./references#CD012071-bbs2-0009" title="Beck‐SagueC , AlexanderER . Failure of benzathine penicillin G treatment in early congenital syphilis. Pediatric Infectious Disease Journal1987;6:1061‐4. ">Beck‐Sague 1987</a>; <a href="./references#CD012071-bbs2-0036" title="IkedaMK , JensonHB . Evaluation and treatment of congenital syphilis. Journal of Pediatrics1990;117:843‐52. ">Ikeda 1990</a>). Concerns have also been raised about the adequacy of concentrations in cerebrospinal fluid of penicillin when babies with congenital syphilis are treated with procaine and aqueous penicillin and benzathine penicillin (<a href="./references#CD012071-bbs2-0076" title="SpeerME , TaberLH , ClarkDB , RudolphAJ . Cerebrospinal fluid levels of benzathine penicillin G in the neonate. Journal of Pediatrics1977;91(6):996‐7. ">Speer 1977</a>). </p> <p>Although antibiotics other than penicillin (e.g. azithromycin, doxycycline and tetracycline) are occasionally used to treat syphilis in adults, given the effectiveness of penicillin in the treatment of majority of cases of congenital syphilis it is extremely rare for other antibiotics to be used. Azithromycin has been used for the treatment of syphilis in adults since the late 1990s with occasional resistance being reported. The most frequent problem with the use of macrolides is the increased percentage of strains with genetic mutations with more likely resistance and therapeutic failure (<a href="./references#CD012071-bbs2-0039" title="KatzKA , KlausnerJD . Azithromycin resistance in Treponema pallidum . Current Opinion in Infectious Diseases2008;21:83‐91. ">Katz 2008</a>). This example, with macrolide resistance of <i>T pallidum</i> shows the capacity of the micro‐organism for change in the genetic code and a mechanism for the development of resistance for other antibiotics (<a href="./references#CD012071-bbs2-0077" title="StammLV . Syphilis: antibiotic treatment and resistance. Epidemiology and Infection2015;143:1567‐74. ">Stamm 2015</a>). Occasionally, the third‐generation cephalosporin ceftriaxone has been used to treat congenital syphilis (<a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>). Even when infants and children who require treatment for syphilis have a history of penicillin allergy or develop an allergic reaction presumed secondary to penicillin they are usually, if necessary, desensitised, and then treated with penicillin (<a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>). </p> <p>The US CDC in its latest guidelines recommends three alternative regimens for the treatment of babies with congenital syphilis (<a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>): </p> <p> <ul id="CD012071-list-0005"> <li> <p>aqueous crystalline penicillin G 100,000 units/kg/day to 150,000 units/kg/day, administered as 50,000 units/kg/dose intravenously every 12 hours during the first seven days of life and every eight hours thereafter for a total of 10 days; OR </p> </li> <li> <p>procaine penicillin G 50,000 units/kg/dose intramuscularly in a single daily dose for 10 days OR </p> </li> <li> <p>benzathine penicillin G 50,000 units/kg/dose intramuscularly in a single dose.</p> </li> </ul> </p> <p>The WHO in 2016 made the following specific recommendations for the treatment of congenital syphilis (<a href="./references#CD012071-bbs2-0092" title="World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis). Geneva: WHO, 2016. ">WHO 2016</a>). </p> <p> <ul id="CD012071-list-0006"> <li> <p>In infants with confirmed congenital syphilis or infants who are clinically normal, but whose mothers had untreated syphilis, inadequately treated syphilis (including treatment within 30 days of delivery) or syphilis that was treated with non‐penicillin regimens, the WHO sexually transmitted infections (STI) guideline suggests aqueous benzyl penicillin or procaine penicillin. Either: </p> <ul id="CD012071-list-0007"> <li> <p>aqueous benzyl penicillin 100,000 units/kg/day to 150,000 units/kg/day intravenously for 10 to 15 days or </p> </li> <li> <p>procaine penicillin 50,000 units/kg/day single dose intramuscularly for 10 to 15 days.</p> </li> </ul> </li> <li> <p>In infants who have no clinical signs of infection with syphilis and whose mothers had syphilis that was adequately treated with no signs of reinfection, the WHO guideline suggests close monitoring of the infants. If decided to treat: </p> <ul id="CD012071-list-0008"> <li> <p>benzathine penicillin G 50,000 units/kg/day single dose intramuscularly.</p> </li> </ul> </li> </ul> </p> <p>It was noted that both recommendations were conditional and based on very low‐quality evidence. </p> </section> <section id="CD012071-sec-0045"> <h3 class="title" id="CD012071-sec-0045">How the intervention might work</h3> <p>Treatment with antibiotics could decrease the risk of neonatal death, improve quality of life and reduce risk of neurological impairment or the sequelae of congenital syphilis. Penicillin is a β‐lactam antibiotic that functions at the level of the cell wall via binding to penicillin‐binding proteins (PBPs) and when bound, the β‐lactam (penicillin) is able to interfere with the production of specific peptidoglycans critical for cell wall structure. Once these peptides are eliminated, the cell wall ruptures and the bacteria dies (<a href="./references#CD012071-bbs2-0069" title="RougasS . From the archives: why is syphilis still sensitive to penicillin? 2012. www.clinicalcorrelations.org/?p=5134 (accessed prior to 19 Nocember 2018). ">Rougas 2012</a>) </p> <p>Ceftriaxone is a third‐generation cephalosporin antibiotic. Like other third‐generation cephalosporins, it has broad‐spectrum activity. It inhibits bacterial cell wall synthesis by means of binding to the PBPs. Inhibition of PBPs in turn inhibit the transpeptidation step in peptidoglycan synthesis which is required for bacterial cell wall formation. The half‐life of ceftriaxone is about seven hours. A range of adverse effects have been reported for ceftriaxone, particularly in neonates (see Ceftriaxone – safety in neonates. Second Meeting of the Subcommittee of the WHO Expert Committee on the Selection and Use of Essential Medicines, Geneva, 29 September to 3 October 2008, <a href="http://www.who.int/selection_medicines/committees/subcommittee/2/Ceftriaxone.pdf" target="_blank">www.who.int/selection_medicines/committees/subcommittee/2/Ceftriaxone.pdf</a>). </p> <p>While there has not yet been resistance of the spirochete to penicillin, caution should be maintained. Cases of syphilis have been increasing worldwide, and so does the potential for antibiotic resistance. A mutation in a PBP (e.g. Tp47) may alter the protective byproducts upon which the sensitivity of syphilis to penicillin depends. Such a mutation would likely result in profound problems in the efficacious treatment of syphilis. </p> </section> <section id="CD012071-sec-0046"> <h3 class="title" id="CD012071-sec-0046">Why it is important to do this review</h3> <p>While the mainstay of treatment of congenital syphilis has been (and remains) penicillin and not other antibiotics such as azithromycin and ceftriaxone, there is some uncertainty about the most appropriate dose and length of treatment. In addition, there is concern about the most appropriate treatment in babies born to mothers also infected with HIV. It is likely that many babies will continue to be born with congenital syphilis and consequently there continues to be a need to clarify issues related to the treatment of this condition (<a href="./references#CD012071-bbs2-0027" title="GoodeL . Blogmaster. Are point‐of‐care tests the answer to meeting WHO target for congenital syphilis? 2013 March. blogs.bmj.com/sti/2013/04/03/are‐point‐of‐care‐tests‐the‐answer‐to‐meeting‐who‐target‐for‐congenital‐syphilis/ (accessed prior to 18 November 2018). ">Goode 2013</a>). </p> <p>As made clear earlier, congenital syphilis is a tragedy for families, accounts for a substantial burden of disease (<a href="./references#CD012071-bbs2-0052" title="MurrayCJ , VosT , LozanoR , NaghaviM , FlaxmanAD , MichaudC , et al. Disability‐adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380:2197‐223. ">Murray 2012</a>), and has significant implications for health services (<a href="./references#CD012071-bbs2-0008" title="BatemanDA , PhibbsCS , JoyceT , HeagartyMC . The hospital cost of congenital syphilis. Journal of Pediatrics1997;130(5):752‐8. ">Bateman 1997</a>; <a href="./references#CD012071-bbs2-0054" title="Owusu‐EduseiKJ , IntrocasoCE , ChessonHW . Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States. Sexually Transmitted Diseases2013;40(3):226‐9. ">Owusu‐Edusei 2013</a>). This would be appreciably increased if resistance to penicillin were to occur and would present even greater challenges and result in increased costs to individuals and health services. Now is an opportune time to clarify which antibiotics are effective in treating congenital syphilis, and avoid increased rates of resistance to antibiotics that can offer the same degree of effectiveness to that of penicillin </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012071-sec-0047" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012071-sec-0047"></div> <p>To assess the effectiveness and safety of antibiotic treatment for newborns with confirmed, highly probable and possible congenital syphilis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012071-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012071-sec-0048"></div> <section id="CD012071-sec-0049"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012071-sec-0050"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs), published and unpublished, that compared the use of antibiotic treatment (any concentration, frequency, duration and route) with no intervention or any other antibiotic treatment (any concentration, frequency, duration and route) for the treatment of neonates with confirmed, highly probable and possible congenital syphilis. </p> <p>We excluded quasi‐randomised trials because this approach produces effect estimates that indicate more extreme benefits compared with those generated by RCTs (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). We also excluded cross‐over trials and cluster‐randomised trials because of the nature of the condition (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). </p> </section> <section id="CD012071-sec-0051"> <h4 class="title">Types of participants</h4> <p>Newborns with confirmed, highly probable or possible congenital syphilis according to CDC definition (<a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>). Neonates were included regardless of the mother’s HIV status. </p> </section> <section id="CD012071-sec-0052"> <h4 class="title">Types of interventions</h4> <p>Antibiotic treatment (at any concentration, frequency, duration and route) versus one of the following: </p> <p> <ul id="CD012071-list-0009"> <li> <p>no intervention;</p> </li> <li> <p>any other antibiotic treatment (any concentration, frequency, duration and route).</p> </li> </ul> </p> </section> <section id="CD012071-sec-0053"> <h4 class="title">Types of outcome measures</h4> <section id="CD012071-sec-0054"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012071-list-0010"> <li> <p>Neonatal death rate due to congenital syphilis.</p> </li> <li> <p>Neonatal death rate due to any cause.</p> </li> <li> <p>Absence of clinical manifestations of congenital syphilis during follow‐up (defined as proportion of newborns without hepatosplenomegaly, lymphadenopathy, organ involvement or any other clinical manifestation after treatment). </p> </li> <li> <p>Serious adverse events (proportion of neonates who experience any adverse effect that was life‐threatening or required discontinuation of therapy or intervention to prevent permanent impairment or damage). </p> </li> </ul> </p> </section> <section id="CD012071-sec-0055"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012071-list-0011"> <li> <p>Serological cure (defined as four‐fold decrease or greater in non‐treponemal tests titre by the third month of age). </p> </li> <li> <p>Minor adverse events of therapy (e.g. fever, diarrhoea, vomiting or allergic reactions).</p> </li> </ul> </p> </section> </section> </section> <section id="CD012071-sec-0056"> <h3 class="title">Search methods for identification of studies</h3> <p>We followed the recommendations suggested by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>), and we published our protocol before conducting the literature search (<a href="./references#CD012071-bbs2-0101" title="WalkerGJA , WalkerD , Molano FrancoD . Antibiotics for congenital syphilis. Cochrane Database of Systematic Reviews2016, Issue 2. [DOI: 10.1002/14651858.CD012071] ">Walker 2016</a>). We attempted to identify RCTs of "antibiotics" for "congenital syphilis," irrespective of language of publication, publication date and publication status (published, unpublished, in press and in progress). We used both electronic searching in bibliographic databases and handsearching, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). </p> <section id="CD012071-sec-0057"> <h4 class="title">Electronic searches</h4> <p>We contacted the Information Specialist of the Cochrane Sexually Transmitted Infections Group to implement a comprehensive search strategy to capture as many relevant studies as possible in electronic databases. For this purpose, we used a combination of exploded controlled vocabulary (MeSH, Emtree, DeCS) and free‐text terms (considering spelling variants, plurals, synonyms, acronyms and abbreviations) for "antibiotics" and "congenital syphilis," with field labels, truncation, proximity operators and Boolean operators. The sensitivity of the search strategies was improved by including keywords from relevant studies detected by earlier searches. The search strategies can be found in <a href="./appendices#CD012071-sec-0118">Appendix 1</a>. </p> <p>Specifically, we searched the following electronic databases:</p> <p> <ul id="CD012071-list-0012"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), Ovid: inception to 23 May 2018; </p> </li> <li> <p>MEDLINE, Ovid: inception to 23 May 2018;</p> </li> <li> <p>MEDLINE In‐Process &amp; Other Non‐Indexed Citations, Ovid: inception to 23 May 2018;</p> </li> <li> <p>MEDLINE Daily Update, Ovid: inception to 23 May 2018;</p> </li> <li> <p>Embase.com: inception to 23 May 2018;</p> </li> <li> <p>LILACS, iAHx interface: inception to 23 May 2018;</p> </li> </ul> </p> <p>For MEDLINE, we used the Cochrane highly‐sensitive search strategy for identifying RCTs: sensitivity and precision maximising version (2008 revision), Ovid format (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). The LILACS search strategy was combined with the RCT filter of the iAHx interface. </p> </section> <section id="CD012071-sec-0058"> <h4 class="title">Searching other resources</h4> <p>We searched the following resources for additional trials.</p> <p> <ul id="CD012071-list-0013"> <li> <p>The STI Cochrane Review Group's Specialized Register, which includes RCTs and controlled clinical trials, from 1944 to 23 May 2018, located through: </p> <ul id="CD012071-list-0014"> <li> <p>electronic searching in CENTRAL, MEDLINE and Embase;</p> </li> <li> <p>online handsearching in those journals not indexed in MEDLINE or Embase, according to the Journals' Master List of the STI Cochrane Review Group. </p> </li> </ul> </li> <li> <p>Trials registers:</p> <ul id="CD012071-list-0015"> <li> <p>WHO International Clinical Trials Registry Platform ICTRP portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>): inception to 23 May 2018; </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>): inception to 23 May 2018. </p> </li> </ul> </li> </ul> <ul id="CD012071-list-0016"> <li> <p>Grey literature in System for Information on Grey Literature in Europe "OpenGrey" (<a href="http://www.opengrey.eu/" target="_blank">www.opengrey.eu/</a>): inception to 23 May 2018. </p> </li> <li> <p>We contacted the trial authors of all RCTs we identified by other methods. A list of RCTs included in the review along with the criteria for considering studies was sent to one of the authors of each included study, asking for any additional studies, published or unpublished, that might be relevant. </p> </li> <li> <p>We handsearched conference proceeding abstracts of the following events:</p> <ul id="CD012071-list-0017"> <li> <p>International Society for Sexually Transmitted Diseases Research (ISSTDR; <a href="http://www.isstdr.org/" target="_blank">www.isstdr.org/</a>): 2007, 2009, 2011, 2013 and 2015; </p> </li> <li> <p>British Association for Sexual Health and HIV (BASHH; <a href="http://www.bashh.org/" target="_blank">www.bashh.org/</a>): 2004, 2006, 2007 and 2009; </p> </li> <li> <p>International Congress on Infectious Diseases (ICID; <a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2010 and 2012; </p> </li> <li> <p>International Union against Sexually Transmitted Infections (IUSTI; <a href="http://www.iusti.org/" target="_blank">www.iusti.org/</a>): 2011 and 2012; </p> </li> <li> <p>International Society for Infectious Diseases (ISID; <a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2011; </p> </li> <li> <p>International Meeting on Emerging Diseases and Surveillance (IMED; <a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2007, 2009 and 2011; </p> </li> <li> <p>Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC; <a href="http://www.icaac.org/" target="_blank">www.icaac.org/</a>): 2011 and 2012; </p> </li> <li> <p>International Federation of Gynecology and Obstetrics (FIGO; <a href="http://www.figo2012.org/home/" target="_blank">www.figo2012.org/home/</a>): 2009, 2012 and 2015. </p> </li> </ul> </li> <li> <p>We handsearched relevant publications on congenital syphilis. This included online searching of certain journals from the early part of the 20th century including the <i>American Journal of Diseases of Childhood</i> , <i>Journal of Pediatics</i> , <i>Archives of Dermatology and Syphilology</i> , <i>Lancet</i> , <i>BMJ</i> , <i>Acta Dermato‐Venereologica</i> and <i>Journal of Venereal Disease Information</i>. </p> </li> <li> <p>Handsearching the reference lists of all relevant RCTs identified by other methods.</p> </li> </ul> </p> </section> </section> <section id="CD012071-sec-0059"> <h3 class="title" id="CD012071-sec-0059">Data collection and analysis</h3> <section id="CD012071-sec-0060"> <h4 class="title">Selection of studies</h4> <p>We downloaded and managed the results of all searches using Endnote bibliographic software. We removed duplicate records of the same study and obtained the full texts of possibly relevant studies. The review authors (GW, DW, DF and CFG‐A) independently assessed for inclusion all the titles, abstracts and full texts of records retrieved from the search strategy. The review authors (GW, DW, DF and CFG‐A) independently undertook the final selection of studies included in the review and resolved disagreements through discussion. </p> </section> <section id="CD012071-sec-0061"> <h4 class="title">Data extraction and management</h4> <p>One review author (GW) designed a form to extract data. This was based on a form used by the Cochrane STI Group. The review authors (GW, DW, DF and CFG‐A) independently extracted the data from eligible studies using the data extract form. We discussed any disagreements regarding extracted data until we reached consensus. </p> <p>We extracted the following data.</p> <p> <ul id="CD012071-list-0018"> <li> <p>Methods:</p> <ul id="CD012071-list-0019"> <li> <p>location of the study and setting;</p> </li> <li> <p>trial design;</p> </li> <li> <p>power calculation performed;</p> </li> <li> <p>methods used to generate and maintain allocation;</p> </li> <li> <p>use of any method of blinding of the researchers or participants (i.e. their parents) in order to evaluate outcomes. </p> </li> </ul> </li> <li> <p>Participants:</p> <ul id="CD012071-list-0020"> <li> <p>inclusion and exclusion criteria;</p> </li> <li> <p>total number of intervention groups;</p> </li> <li> <p>baseline information on the participants in order to have comparable intervention groups at entry; </p> </li> <li> <p>number of participants enrolled, randomised, excluded after randomisation and analysed;</p> </li> <li> <p>number of participants lost to follow‐up in the groups.</p> </li> </ul> </li> <li> <p>Intervention and comparison:</p> <ul id="CD012071-list-0021"> <li> <p>types of interventions: antibiotics (any concentration, frequency and duration of therapy); </p> </li> <li> <p>adherence to the planned intervention and other interventions in the groups under evaluation; </p> </li> <li> <p>types of comparison: no intervention or any antibiotic treatment.</p> </li> </ul> </li> <li> <p>Outcomes:</p> <ul id="CD012071-list-0022"> <li> <p>how outcomes were defined;</p> </li> <li> <p>time of follow‐up of participants to measure outcomes;</p> </li> <li> <p>differences between groups for outcome assessment;</p> </li> <li> <p>outcomes stated in methods versus outcomes reported in results.</p> </li> </ul> </li> <li> <p>Others:</p> <ul id="CD012071-list-0023"> <li> <p>funding sources, reported;</p> </li> <li> <p>ethical issues: use of signed informed consent and ethics approval.</p> </li> </ul> </li> </ul> </p> <p>We entered data into Review Manager 5 (<a href="./references#CD012071-bbs2-0063" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), and checked them for ensuring data accuracy. When information regarding any of the above was unclear, we attempted to obtain clarification by contacting authors of the original reports to ask for further details. For a single RCT report, we extracted data directly onto a data collection form and in case of multiple reports, we extracted data from each report separately, and then combined information across data collection forms. We cross checked to ensure there were no duplicated data. </p> </section> <section id="CD012071-sec-0062"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>All review authors (GW, DW, DF and CFG‐A) independently assessed the risk of bias for each included study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). We resolved disagreements by discussion. The review authors assessing risk of bias were content and methodology experts. When we needed to obtain missing information, we contacted the study investigators using open‐ended questions. We assessed risk of bias in the included trials and collected information in data extraction forms. We then added the information to Review Manager 5 (<a href="./references#CD012071-bbs2-0063" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>We evaluated the following topics proposed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to assess the risk of bias in the included studies (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). </p> <p> <ul id="CD012071-list-0024"> <li> <p>Random sequence generation: it refers to the method of randomisation.</p> </li> <li> <p>Allocation concealment: to assess the risk of selection bias.</p> </li> <li> <p>Blinding of participants and personnel: to evaluate the possible performance bias.</p> </li> <li> <p>Blinding of outcome assessment: to evaluate the possible detection bias.</p> </li> <li> <p>Incomplete outcome data: to determine attrition bias due to withdrawals, dropouts and protocol deviations. </p> </li> <li> <p>Selective outcome reporting: to evaluate possible selective reporting of outcomes.</p> </li> <li> <p>Other sources of bias.</p> </li> </ul> </p> <section id="CD012071-sec-0063"> <h5 class="title">Overall risk of bias</h5> <p>To summarise the quality of the evidence, we considered sequence generation, blinding of outcome assessor, incomplete outcome data and selective reporting domains to classify each study as: </p> <p> <ul id="CD012071-list-0025"> <li> <p>low risk of bias when we judged all four criteria at low risk of bias;</p> </li> <li> <p>high risk of bias when we judged at least one criterion at high risk of bias;</p> </li> <li> <p>unclear risk of bias when we judged all four criteria at unclear risk of bias and moderate risk of bias in the remaining cases (<a href="./references#CD012071-bbs2-0067" title="RomeroL , HuerfanoC , Grillo‐ArdilaCF . Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults. Cochrane Database of Systematic Reviews2017, Issue 12. [DOI: 10.1002/14651858.CD012492.pub2] ">Romero 2017</a>). </p> </li> </ul> </p> <p>We explored the impact of the level of bias through undertaking sensitivity analyses (see <a href="#CD012071-sec-0071">Sensitivity analysis</a>). </p> </section> </section> <section id="CD012071-sec-0064"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data, we presented results as summary risk ratio (RR) with 95% confidence intervals (CI). The RR as a relative effect measure has consistency, works well with a low or high rate of events, and it is easy to interpret and use in clinical practice. </p> </section> <section id="CD012071-sec-0065"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was infants with confirmed, highly probable or possible congenital syphilis who were treated. In updates of this review, if we identify a clinical trial in which participants were randomised to several intervention groups, we will determine which intervention groups were relevant and to avoid confusion for the reader, we will report all intervention groups of the study in the <a href="./references#CD012071-sec-0127" title="">Characteristics of included studies</a> table, and will provide a detailed description of the intervention groups relevant to the review and only use these groups in our analyses. To avoid a unit‐of‐analysis error for a study that could contribute multiple, correlated, comparisons, we will combine groups to create a single pair‐wise comparison. </p> </section> <section id="CD012071-sec-0066"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effects by using sensitivity analysis. For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis (i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated), regardless of whether or not they received the allocated intervention. We contacted the study investigators to request the missing data. </p> </section> <section id="CD012071-sec-0067"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the I<sup>2</sup> statistic and Chi<sup>2</sup> test values (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). We regarded heterogeneity as substantial if the I<sup>2</sup> statistic was greater than 40% and if we found a low P value less than 0.10 in the Chi<sup>2</sup> test for heterogeneity, which we plotted in a forest plot (<a href="./references#CD012071-bbs2-0063" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>We planned to quantify statistical heterogeneity with the I<sup>2</sup> statistic, using the following cut‐off values for interpretation: </p> <p> <ul id="CD012071-list-0026"> <li> <p>0% to 39%: statistical heterogeneity may be negligible;</p> </li> <li> <p>40% to 60%: statistical heterogeneity may be moderate;</p> </li> <li> <p>greater than 60%: statistical heterogeneity may be substantial.</p> </li> </ul> </p> </section> <section id="CD012071-sec-0068"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to explore publication bias through assessment of funnel plot asymmetry and formal tests. For dichotomous outcomes, we planned to use the test proposed by <a href="./references#CD012071-bbs2-0030" title="HarbordRM , EggerM , SterneJA . A modified test for small‐study effects in meta‐analysis of controlled trials with binary endpoints. Statistics in Medicine2006;25(20):3443‐57. ">Harbord 2006</a>. However, we included fewer than 10 trials in the meta‐analysis, so we did not perform these analyses. </p> </section> <section id="CD012071-sec-0069"> <h4 class="title">Data synthesis</h4> <p>We performed statistical analyses using Review Manager 5 (<a href="./references#CD012071-bbs2-0063" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used a fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect (i.e. where trials were examining the same intervention, and the trial populations and methods were judged sufficiently similar). If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if we detected moderate or substantial statistical heterogeneity, we used a random‐effects meta‐analysis to produce an overall summary if a mean treatment effect across trials was considered clinically meaningful. We treated the random‐effects summary as the mean range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the mean treatment effect was not clinically meaningful, we did not combine trials. </p> <p>If we used random‐effects analyses, we presented the results as the mean treatment effect with 95% CIs, and the estimates of the Tau<sup>2</sup> and I<sup>2</sup> statistics. </p> </section> <section id="CD012071-sec-0070"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to undertake the following subgroup analyses:</p> <p> <ul id="CD012071-list-0027"> <li> <p>according to congenital syphilis CDC definition (confirmed, highly probable or possible);</p> </li> <li> <p>comparison of different maternal HIV serostatus (positive or negative);</p> </li> <li> <p>comparison of different antibiotic type;</p> </li> <li> <p>setting (high‐income versus middle‐ and low‐income countries).</p> </li> </ul> </p> <p>We planned to restricted subgroup analyses to the outcomes: neonatal death rate due congenital syphilis, neonatal death rate due any causes, absence of clinical manifestations of congenital syphilis during follow‐up and serious adverse events. </p> </section> <section id="CD012071-sec-0071"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses for aspects of the review that might have affected the results, for example, where there was risk of bias associated with the quality of some of the included trials (low versus unclear or high risk of bias). </p> <section id="CD012071-sec-0072"> <h5 class="title">'Summary of findings' table</h5> <p>We prepared 'Summary of findings' tables using GRADEpro (<a href="./references#CD012071-bbs2-0029" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 26 March 2018. Hamilton (ON): GRADE Working Group, McMaster University, 2015. Available at gradepro.org. ">GRADEpro GDT 2015</a>) and Cochrane methods (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). These tables evaluate the overall quality of the body of evidence for the review outcomes (neonatal death rate due to congenital syphilis, neonatal death rate due to any cause, absence of clinical manifestations of congenital syphilis during follow‐up, serious adverse events, serological cure and minor adverse events) for the main review comparisons (antibiotic treatment versus no intervention and antibiotic treatment versus any other antibiotic). We assessed the quality of the evidence using GRADE criteria: risk of bias, consistency of effect, imprecision, indirectness and publication bias). All review authors (GW, DW, DF and CFG‐A) independently made judgements about evidence quality (high, moderate, low or very low), with disagreements resolved by discussion. We justified, documented and incorporated judgements into reporting of results for each outcome. </p> <p>We planned to extract study data, format our comparisons in data tables and prepare 'Summary of findings' tables before writing the results and conclusions of our review. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012071-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012071-sec-0073"></div> <section id="CD012071-sec-0074"> <h3 class="title">Description of studies</h3> <section id="CD012071-sec-0075"> <h4 class="title">Results of the search</h4> <p>We searched the available literature up to 23 May 2018. We retrieved 106 references, of which we screened 69 after we removed duplicates. Of these, we retrieved the full‐text of three references. Two published trials (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>; <a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>) meet our eligibility criteria for inclusion. We excluded one study (see the <a href="./references#CD012071-sec-0128" title="">Characteristics of excluded studies</a>). We presented a PRISMA diagram in <a href="#CD012071-fig-0001">Figure 1</a> to illustrate the study selection process. </p> <div class="figure" id="CD012071-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012071-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012071-sec-0076"> <h4 class="title">Included studies</h4> <p>The two included trials had 174 participants with a sample size of 22 (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>) and 152 (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). One was from South Africa (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>), and the other from the USA (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). None were multicentric, and, despite that, one of them used a method for sample size calculation (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>), this target for recruitment was not achieved because the study was stopped early after there were several cases of congenital syphilis in the no treatment group. The Included trials recruited their participants from public and private specialist hospital units and received ethics and research committee approval. One was sponsored by an academic institution (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>), and it was not clear if the other received any outside financial support (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). The reports of both trials were published in English. </p> <section id="CD012071-sec-0077"> <h5 class="title">Population</h5> <p>The two trials included newborns with possible congenital syphilis. Mothers were diagnosed with gestational syphilis during their antenatal care using the combination of treponemal and non‐treponemal test and were interviewed soon after birth. Infants of mothers who had not received treatment, or whose treatment for syphilis during pregnancy was inadequate, were eligible for inclusion. Only infants who could be followed up were included and infants were recruited regardless of the presence of comorbidities or maternal risk behaviour (e.g. HIV status, drug users) or their gestational age, birthweight, race or sex. All newborns received a complete physical examination after birth and before their inclusion in the trials. </p> <p>For the first trial, infants were eligible for the study if they met the following criteria were met: </p> <p> <ul id="CD012071-list-0028"> <li> <p>neonate born to a mother with positive RPR and microhaemagglutination assay for <i>T pallidum</i> antibodies (MHA‐TP) results at time of delivery; </p> </li> <li> <p>no or inadequate treatment of syphilis in the mother;</p> </li> <li> <p>no systemic antibiotics given to the infant before enrolment;</p> </li> <li> <p>no signs of congenital syphilis on physical examination, cerebrospinal fluid cell count or VDRL test, x‐ray study of long bones and platelet count or liver function tests. </p> </li> </ul> </p> <p>Infants were not eligible for the study if cerebrospinal fluid was not obtained for the VDRL test and cell count. Enrolled infants were considered to be at high risk of acquiring congenital syphilis if they had any of the following: no maternal treatment of syphilis, positive fluorescent treponemal antibody immunoglobulin M (FTA‐IgM) results, infant's RPR titre at least four‐fold higher at birth than the mother's or serum HIV antibody (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). </p> <p>The second study recruited asymptomatic infants with congenital syphilis (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). This category was defined as those born to mothers with untreated syphilis (i.e. positive VDRL and treponema pallidum haemagglutination (TPHA) tests), with a VDRL titre of 32 or more. Infants were regarded as asymptomatic at birth if: there were no clinical signs of congenital syphilis; the x‐rays of the long bones were normal and the rheumatoid factor latex test was negative at birth. </p> </section> <section id="CD012071-sec-0078"> <h5 class="title">Intervention and comparison</h5> <p>The intervention was similar for both trials, being the antibiotic benzathine penicillin 50,000 units/kg in a single intramuscular injection (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>; <a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). One trial compared the intervention with no treatment (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>); while the other trial used procaine benzylpenicillin 50,000 units/kg given daily intramuscularly for 10 days (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). </p> </section> <section id="CD012071-sec-0079"> <h5 class="title">Outcomes</h5> <p>Included trials reported at least one prespecified primary outcome of this review. The largest trial was scheduled to follow‐up babies at two to three months, five to six months and 12 months of age (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). The trial comparing benzathine penicillin with no treatment included reporting the proportion of neonates with abnormal physical examination suggestive of congenital syphilis at the third month of age, follow‐up was planned at six‐weekly intervals after birth but the trial was stopped early after there were several cases of congenital syphilis found within 12 weeks of entry into the trial in the no treatment group (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). </p> <p>The included studies assessed serological cure defined as a four‐fold (or greater) decrease in the non‐treponemal titre within 12 weeks of entry into the trial. One study reported the neonatal death rate due any cause at the end of follow‐up (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>), and the other trial reported the neonatal death rate due congenital syphilis at 12 months of age (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). Finally, included studies reported the proportion of neonates with abnormal physical examination suggestive of congenital syphilis at the third month of age. We obtained no data for the primary outcome of serious adverse events or for the secondary outcome of minor adverse events. </p> </section> </section> <section id="CD012071-sec-0080"> <h4 class="title">Excluded studies</h4> <p>The one excluded trial (<a href="./references#CD012071-bbs2-0003" title="VenterA , PettiforJM , DuursmaJ , PudifinDJ , SmythA , BeckerPJ . Liver function in early congenital syphilis: does penicillin cause a deterioration?. Journal of Pediatric Gastroenterology and Nutrition1991;12(3):310‐4. VenterA , PettiforJM , NininDT , PudifinDJ , DuursmaJ . Steroid therapy ‐ does it have a role to play in the treatment of congenital syphilis?. Proceedings of the Seventh Conference on the Priorities in Perinatal Care in South Africa, Ceres, , Cape Province. March 8‐11, 1988:70‐73. ">Venter 1986</a>) was designed with the objective to determine if penicillin therapy caused a deterioration in liver function. Infants were randomly assigned into two groups: penicillin therapy only and penicillin plus prednisone as an adjunct. We excluded this trial because it did not compare the use of antibiotic treatment with no intervention or any other antibiotic treatment (see <a href="./references#CD012071-sec-0128" title="">Characteristics of excluded studies</a> table). </p> </section> </section> <section id="CD012071-sec-0081"> <h3 class="title">Risk of bias in included studies</h3> <p>We summarised the risk of bias assessment in <a href="#CD012071-fig-0002">Figure 2</a> and <a href="#CD012071-fig-0003">Figure 3</a>, and included additional details in the <a href="./references#CD012071-sec-0127" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD012071-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012071-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD012071-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012071-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD012071-sec-0082"> <h4 class="title">Allocation</h4> <section id="CD012071-sec-0083"> <h5 class="title">Random sequence generation (selection bias)</h5> <p>One trial adequately reported the random sequence generation method by using a computer‐generated randomisation list, making selection bias at entry unlikely (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). The remaining included trial did not report the random sequence generation method, making the risk of selection bias at entry unclear (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). </p> </section> <section id="CD012071-sec-0084"> <h5 class="title">Allocation concealment (selection bias)</h5> <p>Neither trial described the method used to conceal allocation to interventions prior to assignment and we could not assess whether intervention allocation could have been foreseen in advance of, or during, recruitment or changed after assignment (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>; <a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). We judged them at unclear risk of selection bias. </p> </section> </section> <section id="CD012071-sec-0085"> <h4 class="title">Blinding</h4> <p>One study did not report the method used to blind outcome assessors and personnel regarding which intervention a baby received (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). The second RCT was an open‐label trial; participants were assigned to the intervention (single injection of benzathine penicillin) or no treatment arm (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). However, we considered both studies were at low risk for performance and detection bias because the outcomes of neonatal death due to congenital syphilis or any cause, absence of clinical manifestations of congenital syphilis and serological cure were objectively assessed, so the lack of blinding was unlikely to affect the results. </p> </section> <section id="CD012071-sec-0086"> <h4 class="title">Incomplete outcome data</h4> <p>One trial appropriately stated the attrition and exclusions at each stage and the level of missing data was not over 20% (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). In the no treatment arm of 10 participants, two infants were lost to follow‐up, one after four months who was considered not to be infected because the VDRL had declined to one by four months. The second infant died of diarrhoea aged two months and had no follow‐up VDRL but the study authors considered this infant was not infected. In the treatment arm of 12 infants, one was lost to follow‐up. For this study, the overall assessment of was of low risk because the level of missing data was not over 20% for this outcome. </p> <p>The other study had a low attrition rate for the outcomes of neonatal death rate due congenital syphilis and absence of clinical manifestations of congenital syphilis but an extremely high attrition level for serological cure (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). Initially, this study randomly assigned 169 infants to receive either benzathine penicillin (92 infants) or procaine benzylpenicillin (77 infants). Three infants were excluded from the benzathine penicillin group and five from the procaine benzylpenicillin group because of maternal false‐positive RPR results and positive x‐rays results not recognised before enrolment. Five were lost to follow‐up in the benzathine penicillin group and four in the procaine benzylpenicillin group. Overall, excluded or lost to follow‐up was 8.7% in the benzathine penicillin group and 11.7% in the procaine benzylpenicillin group for the outcomes of neonatal death rate due congenital syphilis and absence of clinical manifestations of congenital syphilis. However, only 129 infants were assessed by four month of follow‐up with RPR titre (68 in the benzathine penicillin arm and 61 in the procaine benzylpenicillin arm). For this study, the overall assessment was of high risk because the level of missing data was over 20% for the outcome of serological cure. </p> </section> <section id="CD012071-sec-0087"> <h4 class="title">Selective reporting</h4> <p>The trial protocols were not available for either of the included trials and it was unclear if the published reports included all the expected outcomes, including those that were prespecified. The published reports had insufficient information to permit a judgement of 'yes' or 'no' and consequently were rated at unclear risk of reporting bias. </p> </section> <section id="CD012071-sec-0088"> <h4 class="title">Other potential sources of bias</h4> <p>One study had a potential source of bias related to a formal 'stopped early' rule due to apparent benefit (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). The remaining retrieved trial was sponsored by an academic institution (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). This study appeared to be free from other sources of bias and was at low risk of other bias. </p> </section> </section> <section id="CD012071-sec-0089"> <h3 class="title" id="CD012071-sec-0089">Effects of interventions</h3> <p>See: <a href="./full#CD012071-tbl-0001"><b>Summary of findings for the main comparison</b> Antibiotic treatment compared to no intervention for newborns with congenital syphilis</a>; <a href="./full#CD012071-tbl-0002"><b>Summary of findings 2</b> Antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for newborns with congenital syphilis</a> </p> <p>See: <a href="./full#CD012071-tbl-0001">summary of findings Table for the main comparison</a> for the main comparison antibiotic treatment versus no intervention; This trial was stopped early because there were four cases with clinical congenital syphilis in the no treatment group and none in the treatment group. <a href="./full#CD012071-tbl-0002">summary of findings Table 2</a> for antibiotic treatment compared to any other antibiotic treatment. The sources of all data presented in the review were published literature. </p> <section id="CD012071-sec-0090"> <h4 class="title">1. Antibiotic treatment compared to no intervention</h4> <p>Only one trial including 22 participants compared benzathine penicillin versus no intervention for infants with possible congenital syphilis (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). This study had intended to recruit 60 infants but the trial was terminated early following an interim analysis when 22 babies had been recruited. </p> <section id="CD012071-sec-0091"> <h5 class="title">1.1. Neonatal death rate due to congenital syphilis</h5> <p>The trial did not report neonatal death due to congenital syphilis.</p> </section> <section id="CD012071-sec-0092"> <h5 class="title">1.2. Neonatal death rate due to any cause</h5> <p>In the benzathine penicillin group of 12 babies, one died at two weeks of a congenital heart defect (hypoplastic left heart disease); and in the no treatment group of 10 newborns, nine survived and one died of diarrhoeal disease at age two months. There was little or no difference between antibiotic treatment and no intervention in terms of neonatal death rate due to any cause (RR 0.83, 95% CI 0.06 to 11.70; 1 study, 22 infants; <a href="./references#CD012071-fig-0007" title="">Analysis 1.1</a>). The quality of the evidence was low due to limitations on risk of bias and imprecision. </p> </section> <section id="CD012071-sec-0093"> <h5 class="title">1.3. Absence of clinical manifestations of congenital syphilis during follow‐up</h5> <p>In the benzathine penicillin group, no infants developed physical signs suggestive of congenital syphilis. However, four participants assigned to the no intervention group had clinical manifestations of congenital syphilis but results showed little or no difference between the groups (RR 0.12, 95% CI 0.01 to 2.09; 1 study, 22 infants; <a href="./references#CD012071-fig-0008" title="">Analysis 1.2</a>). The quality of the evidence was low due to limitations of precision and risk of bias. </p> </section> <section id="CD012071-sec-0094"> <h5 class="title">1.4. Serious adverse events</h5> <p>The trial did not report serious adverse events.</p> </section> <section id="CD012071-sec-0095"> <h5 class="title">1.5. Serological cure</h5> <p>In the group treated with benzathine penicillin of 11 babies with follow‐up, VDRL titres of all newborns declined to zero in the absence of any signs of congenital syphilis; and in the no treatment group of nine infants with complete follow‐up, there were only four with a four‐fold decrease or greater in non‐treponemal tests titre by the third month. Antibiotic treatment may have increased the proportion of infants experiencing a four‐fold decrease or greater in non‐treponemal tests titre by the third month (RR 2.13, 95% CI 1.06 to 4.27; 1 study, 20 infants; <a href="./references#CD012071-fig-0009" title="">Analysis 1.3</a>; <a href="#CD012071-fig-0004">Figure 4</a>). The quality of the evidence was low due to limitations of imprecision and risk of bias. </p> <div class="figure" id="CD012071-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Antibiotic treatment compared to no intervention for congenital syphilis, outcome: 1.3 Serological cure (four‐fold decrease or greater in non‐treponemal tests titre)." data-id="CD012071-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antibiotic treatment compared to no intervention for congenital syphilis, outcome: 1.3 Serological cure (four‐fold decrease or greater in non‐treponemal tests titre). </p> </div> </div> </div> </section> <section id="CD012071-sec-0096"> <h5 class="title">1.6. Minor adverse events of therapy</h5> <p>The trial did not report minor adverse events of therapy.</p> </section> </section> <section id="CD012071-sec-0097"> <h4 class="title">2. Antibiotic treatment compared to any other antibiotic treatment</h4> <p>One trial including 152 infants compared benzathine penicillin versus procaine benzylpenicillin for the treatment of newborns with possible congenital syphilis (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). </p> <section id="CD012071-sec-0098"> <h5 class="title">2.1. Neonatal death rate due to congenital syphilis</h5> <p>Of 152 babies followed up (84 in the benzathine penicillin group and 68 in the procaine benzylpenicillin group), all survived. There were no cases of neonatal death due to congenital syphilis. </p> </section> <section id="CD012071-sec-0099"> <h5 class="title">2.2. Neonatal death rate due to any cause</h5> <p>The trial did not report neonatal death due to any cause.</p> </section> <section id="CD012071-sec-0100"> <h5 class="title">2.3. Absence of clinical manifestations of congenital syphilis during follow‐up</h5> <p>No infants developed physical signs suggestive of congenital syphilis during follow‐up. There was no evidence of a difference between benzathine penicillin and procaine benzylpenicillin (RR 1.00, 95% CI 0.97 to 1.03; 1 study, 152 infants; <a href="./references#CD012071-fig-0010" title="">Analysis 2.1</a>; <a href="#CD012071-fig-0005">Figure 5</a>). The quality of the evidence was high. </p> <div class="figure" id="CD012071-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.1 Absence of clinical manifestations of congenital syphilis during follow‐up." data-id="CD012071-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.1 Absence of clinical manifestations of congenital syphilis during follow‐up. </p> </div> </div> </div> </section> <section id="CD012071-sec-0101"> <h5 class="title">2.4. Serious adverse events</h5> <p>The trial did not report serious adverse events.</p> </section> <section id="CD012071-sec-0102"> <h5 class="title">2.5. Serological cure</h5> <p>All babies who were tested in both groups had at least a four‐fold decrease or greater in non‐treponemal tests titre by three months of age. There were probably no differences between benzathine penicillin and procaine benzylpenicillin in terms of serological cure (RR 1.00, 95% CI 0.97 to 1.03; 1 study 129 infants; <a href="./references#CD012071-fig-0011" title="">Analysis 2.2</a>; <a href="#CD012071-fig-0006">Figure 6</a>). The quality of the evidence was moderate due to attrition bias risk. </p> <div class="figure" id="CD012071-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.2 Serological cure (four‐fold decreased or greater in non‐treponemal tests titre)." data-id="CD012071-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.2 Serological cure (four‐fold decreased or greater in non‐treponemal tests titre). </p> </div> </div> </div> </section> <section id="CD012071-sec-0103"> <h5 class="title">2.6. Minor adverse events of therapy</h5> <p>The trial did not report minor adverse events of therapy.</p> </section> </section> <section id="CD012071-sec-0104"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We could not analyse potential sources of heterogeneity using subgroup analysis by congenital syphilis CDC definition, maternal HIV serostatus, antibiotic type or setting (high‐income versus middle‐ and low‐income countries), because of lack of information. </p> </section> <section id="CD012071-sec-0105"> <h4 class="title">Sensitivity analysis</h4> <p>We could not carry out the planned sensitivity analyses based on the quality of the included trials because all of the included studies were assessed at unclear or high risk of bias. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012071-sec-0106" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012071-sec-0106"></div> <section id="CD012071-sec-0107"> <h3 class="title" id="CD012071-sec-0107">Summary of main results</h3> <p>Two RCTs (191 participants) met our inclusion criteria; neither were funded by the pharmaceutical industry (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>; <a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). </p> <p>One trial (22 participants) compared benzathine penicillin administration with no intervention for infants with possible congenital syphilis (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). Low‐quality evidence suggested there was no difference in the rate of neonatal death due to any cause (RR 0.83, 95% CI 0.06 to 11.70; on average, 83 infants per 1000 population with benzathine penicillin versus 100 per 1000 population with no intervention), but there was a possible difference with penicillin on the proportion of neonates with clinical manifestations of congenital syphilis during follow‐up (RR 0.12, 95% CI 0.01 to 2.09; on average, 36 infants per 1000 population with benzathine penicillin versus 300 per 1000 population with no intervention) but the results were imprecise because the trial was stopped early because there were four cases with clinical congenital syphilis in the no treatment group and none in the treatment group. Benzathine penicillin administration increased the serological cure at three months of age (RR 2.13, 95% CI 1.06 to 4.27; on average, 947 infants per 1000 population with benzathine penicillin versus 444 infants per 1000 population with no intervention). These results should be taken with caution, because were mainly driven by one trial. This study did not report neonatal death due to congenital syphilis or the frequency of serious or minor adverse events after therapy. We downgraded the quality of evidence because of imprecision and risk of bias. </p> <p>One trial (169 participants) compared benzathine penicillin versus procaine benzylpenicillin (<a href="./references#CD012071-bbs2-0001" title="ParyaniSG , VaughnAJ , CrosbyM , LawrenceS . Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. Journal of Pediatrics1994;125(3):471‐5. ">Paryani 1994</a>). High‐ and moderate‐quality evidence suggested that there were probably no differences between benzathine penicillin and procaine benzylpenicillin for absence of clinical manifestations of congenital syphilis during follow‐up (RR 1.00, 95% CI 0.97 to 1.03; on average, 1000 infants per 1000 population with benzathine penicillin versus 1000 infants per 1000 population with procaine benzylpenicillin) and serological cure (RR 1.00, 95% CI 0.97 to 1.03; on average, 1000 infants per 1000 population with benzathine penicillin versus 1000 infants per 1000 population with procaine benzylpenicillin). There were no cases of neonatal death due congenital syphilis; all 152 babies who were followed up survived. This study did not report on neonatal death rate due to any cause, or frequency of serious or minor adverse events after therapy. We downgraded the quality of evidence because of serious risk of bias. </p> </section> <section id="CD012071-sec-0108"> <h3 class="title" id="CD012071-sec-0108">Overall completeness and applicability of evidence</h3> <p>Although we conducted comprehensive searches to retrieve all published and unpublished RCTs, this systematic review only identified two trials. Evidence from RCTs suggested that, compared with no intervention, benzathine penicillin administration may have increased serological cure at three months of age (on average, 947 infants per 1000 population with benzathine penicillin versus 444 infants per 1000 population with no intervention). These findings support the current practice, regarding the treatment of babies born with confirmed, highly probable or possible congenital syphilis established over many years of clinical experience. The lack of apparent effect of penicillin for reduction on the frequency of neonates with clinical manifestations of congenital syphilis during follow‐up could be the consequence of low precision results rather than the absence of effect. We were unable to evaluate the primary outcomes: serious adverse events and the secondary outcome of minor adverse events after therapy as neither trial reported these outcomes. </p> <p>It is surprising that so few RCTs have been carried out concerned with the treatment of congenital syphilis and no trials including antibiotics other than different formulations of penicillin. Despite limitations of the completeness of evidence, the results of this systematic review have broad applicability. The review's conclusions can be extrapolated to infants born to mothers diagnosed with gestational syphilis during their antenatal care and who did not receive treatment or whose treatment was inadequate, resulting in the birth of an asymptomatic infant with confirmed, highly probable or possible congenital syphilis. Finally, because the included studies only assessed the effectiveness of the intervention (penicillin), the wider safety of the penicillin therapy and that of any alternative antibiotic, continue to be issues requiring research. </p> </section> <section id="CD012071-sec-0109"> <h3 class="title" id="CD012071-sec-0109">Quality of the evidence</h3> <p>We used the GRADE approach to assess the quality of the evidence and produce 'Summary of findings' tables (<a href="./references#CD012071-bbs2-0033" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Chichester (UK): John Wiley &amp; Sons, 2011. ">Higgins 2011</a>). We attempted to clarify details related to design and execution of the two identified trials by contacting the authors of the papers. However in both cases, the authors were unable to provide additional information. Consequently, the included studies showed flaws related to risk of bias (unclear for selection and reporting bias and high risk for attrition or other potential sources of bias), while for one of the trials, the reviewed evidence showed additional, serious precision limitations (outcome events with wide CIs and some regarding limited numbers included in the trial) (<a href="./references#CD012071-bbs2-0002" title="RadcliffeM , MeyerM , RoditiD , MalanA . Single‐dose benzathine penicillin in infants at risk of congenital syphilis – results of a randomised study. South African Medical Journal1997;87(1):62‐5. ">Radcliffe 1997</a>). </p> <p>We could not evaluate publication bias because there were too few included trials for comparisons. The results of the comparison antibiotic treatment versus non‐intervention should be viewed with caution, as they were based on one small study with low‐quality evidence (see <a href="./full#CD012071-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD012071-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD012071-sec-0110"> <h3 class="title" id="CD012071-sec-0110">Potential biases in the review process</h3> <p>This systematic review has several weaknesses: the limited number of studies undertaken and small numbers involved; both identified RCTs had limitations regarding possible bias. However, the review adhered to a predefined protocol; the search strategy for this review was extensive and included extended methods to identify eligible studies; all review authors independently assessed trials for inclusion, extracted data and assessed the risk of bias in the included studies; we described the included and excluded studies in sufficient detail, providing an explanation for excluded studies and finally, all authors declared no potential conflict of interest. </p> <p>One of the problems in identifying potentially eligible studies is that they are likely to have been conducted in low‐ and middle‐income countries, where congenital syphilis is more common. If such studies are published in journals that are not easy to access, or are unpublished, they may not have been identified by our search strategy. In this sense, we have some concerns about publication bias and related small‐study effects. Due to the low quality of evidence for some outcomes, we have uncertainty for some conclusions of this systematic review. We would welcome information about any potentially eligible studies for this review (please send information to <a class="__cf_email__" data-cfemail="492e262d2f3b2c30673e2825222c3b7f7d0928253c242720672024392c3b20282567282a673c22" href="/cdn-cgi/l/email-protection">[email protected]</a>). </p> </section> <section id="CD012071-sec-0111"> <h3 class="title" id="CD012071-sec-0111">Agreements and disagreements with other studies or reviews</h3> <p>To the best of our knowledge, there are no previous systematic reviews published on this topic. The results of this systematic review showed that compared with no intervention, treatment with benzathine penicillin increased neonatal serological cure at three months of age. This review also found no differences between benzathine penicillin and procaine benzylpenicillin for the treatment of infants with possible or highly probable congenital syphilis. Penicillin for the treatment of congenital syphilis was established shortly after it became available in the 1940s and is based on early case series of its success (<a href="./references#CD012071-bbs2-0006" title="BarkerLP . An evaluation of the penicillin treatment in early congenital syphilis. The Journal of Pediatrics1948;32(5):516‐521. ">Barker 1948</a>, <a href="./references#CD012071-bbs2-0020" title="EnkvistO . Penicillin combined with other treatment in congenital syphilis. Acta Dermato‐Venereologica1948;28(2):104‐115. ">Enkvist 1948</a>, <a href="./references#CD012071-bbs2-0028" title="GoodwinMS . Status of Treatment of Syphilitic Pregnant Women and of Children who have Congenital Syphilis. Journal of Venereal Disease Information1950;31(7):178‐84. ">Goodwin 1950</a>, <a href="./references#CD012071-bbs2-0058" title="PlatouRV , HillAJ , IngrahamNR , GoodwinMS , WilkinsonEE , HansenAE . Penicillin in the treatment of infantile congenital syphilis. A brief preliminary note. JAMA1945;127(10):582. ">Platou 1945</a>, <a href="./references#CD012071-bbs2-0059" title="PlatouRV , HillAI , IngrahamNR , GoodwinMS , WilkinsonEE , HansenAE . Effect of penicillin in the treatment of infantile congenital syphilis, Further observations. The American Journal of Diseases of Children1946;72(6):635‐648. ">Platou 1946</a>, <a href="./references#CD012071-bbs2-0060" title="PlatouRV , HillAJ , IngrahamNR , GoodwinMS , WilkinsonEE , HansenAE , HeymanA . Early congenital syphilis treatment of two hundred and fifty‐two patients with penicillin.. JAMA1947;133(1):10‐16. ">Platou 1947</a>, <a href="./references#CD012071-bbs2-0061" title="PlatouRV . Treatment of congenital syphilis with penicillin. Advances in Pediatrics 4 (1949): 39‐86.1949;4:39‐86. ">Platou 1949</a>, <a href="./references#CD012071-bbs2-0068" title="RoseEK , GyorgyP , IngrahamNR . Treattment of infantile congenital syphilis. Results with aqueous penicillin alone in sixty Infants followed for an average of two years after treatment. The American Journal of Diseases of Children1949;77(6):729‐735. ">Rose 1949</a>). The findings of this review support the recommendations from guideline development groups (<a href="./references#CD012071-bbs2-0012" title="Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Morbidity and Mortality Weekly Report2015;64(3):1‐140. ">CDC 2015</a>; <a href="./references#CD012071-bbs2-0092" title="World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis). Geneva: WHO, 2016. ">WHO 2016</a>), who proposed these therapeutic alternatives for the treatment of babies with asymptomatic congenital syphilis. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012071-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012071-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012071-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012071-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Antibiotic treatment compared to no intervention for congenital syphilis, outcome: 1.3 Serological cure (four‐fold decrease or greater in non‐treponemal tests titre)." data-id="CD012071-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antibiotic treatment compared to no intervention for congenital syphilis, outcome: 1.3 Serological cure (four‐fold decrease or greater in non‐treponemal tests titre). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.1 Absence of clinical manifestations of congenital syphilis during follow‐up." data-id="CD012071-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.1 Absence of clinical manifestations of congenital syphilis during follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.2 Serological cure (four‐fold decreased or greater in non‐treponemal tests titre)." data-id="CD012071-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, outcome: 2.2 Serological cure (four‐fold decreased or greater in non‐treponemal tests titre). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment compared to no intervention for congenital syphilis, Outcome 1 Neonatal death rate due to any cause." data-id="CD012071-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment compared to no intervention for congenital syphilis, Outcome 1 Neonatal death rate due to any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#CD012071-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment compared to no intervention for congenital syphilis, Outcome 2 Absence of clinical manifestations of congenital syphilis during follow‐up." data-id="CD012071-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment compared to no intervention for congenital syphilis, Outcome 2 Absence of clinical manifestations of congenital syphilis during follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#CD012071-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment compared to no intervention for congenital syphilis, Outcome 3 Serological cure (≥ 4‐fold decrease or greater in non‐treponemal tests titre)." data-id="CD012071-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment compared to no intervention for congenital syphilis, Outcome 3 Serological cure (≥ 4‐fold decrease or greater in non‐treponemal tests titre). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#CD012071-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, Outcome 1 Absence of clinical manifestations of congenital syphilis during follow‐up." data-id="CD012071-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, Outcome 1 Absence of clinical manifestations of congenital syphilis during follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#CD012071-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012071-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/urn:x-wiley:14651858:media:CD012071:CD012071-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_t/tCD012071-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, Outcome 2 Serological cure (≥ 4‐fold decrease or greater in non‐treponemal tests titre)." data-id="CD012071-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis, Outcome 2 Serological cure (≥ 4‐fold decrease or greater in non‐treponemal tests titre). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#CD012071-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/media/CDSR/CD012071/image_n/nCD012071-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012071-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic treatment compared to no intervention for newborns with congenital syphilis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Antibiotic treatment compared to no intervention for newborns with congenital syphilis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> newborns with congenital syphilis<br/> <b>Setting:</b> inpatient clinic<br/> <b>Intervention:</b> antibiotic treatment<br/> <b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal death rate due congenital syphilis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neonatal death rate due any cause</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000<br/> (6 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b><br/> (0.06 to 11.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Absence of clinical manifestations of congenital syphilis during follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>36 per 1000<br/> (3 to 627) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.12</b><br/> (0.01 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serological cure (≥ 4‐fold decrease in non‐treponemal tests titre)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>947 per 1000<br/> (471 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.13</b><br/> (1.06 to 4.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor adverse events of therapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations on other bias domain (stopped early rule due to apparent benefit). </p> <p><sup>b</sup>Downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic treatment compared to no intervention for newborns with congenital syphilis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012071-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for newborns with congenital syphilis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for newborns with congenital syphilis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> newborns with congenital syphilis<br/> <b>Setting:</b> inpatient clinic<br/> <b>Intervention:</b> antibiotic treatment (benzathine penicillin)<br/> <b>Comparison:</b> any other antibiotic (procaine benzylpenicillin) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any other antibiotic (procaine benzylpenicillin)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic treatment (benzathine penicillin)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal death rate due congenital syphilis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>There were 0 cases of neonatal death due congenital syphilis.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal death rate due to any cause</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Absence of clinical manifestations of congenital syphilis during follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (970 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b><br/> (0.97 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serological cure (4‐fold decrease or greater in non‐treponemal tests titre)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (970 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b><br/> (0.97 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor adverse events of therapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations on incomplete outcome data domain. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for newborns with congenital syphilis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/full#CD012071-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012071-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic treatment compared to no intervention for congenital syphilis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neonatal death rate due to any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Absence of clinical manifestations of congenital syphilis during follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serological cure (≥ 4‐fold decrease or greater in non‐treponemal tests titre) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic treatment compared to no intervention for congenital syphilis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#CD012071-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012071-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Absence of clinical manifestations of congenital syphilis during follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serological cure (≥ 4‐fold decrease or greater in non‐treponemal tests titre) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any antibiotic treatment (benzathine penicillin) compared to any other antibiotic (procaine benzylpenicillin) for congenital syphilis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012071.pub2/references#CD012071-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012071.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012071-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012071-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012071-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hu#CD012071-note-0011">Magyar</a> </li> <li class="section-language"> <a class="" href="ms#CD012071-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012071-note-0003">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012071-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012071-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012071\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012071\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012071\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012071\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012071\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012071.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012071.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012071.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012071.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012071.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718633966"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012071.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718633970"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012071.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd51fba84f47a',t:'MTc0MDcxODYzNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 